Document:

EX-10.1

 Exhibit 10.1 
  

 
 May 25, 2018 

Mr. Gary L. Sims 
 1972 Marcasite Pl 

Carlsbad, CA 92009 
 RE: Red Lion Hotels Corporation Offer
Letter 
 Dear Gary: 
 On behalf of Red Lion Hotels
Corporation (the “Company”), we are delighted to offer you the position of Executive Vice President, Chief Operating Officer. In your new position, you will report to the President and CEO of the Company. 

As an officer of the Company, the details of your hire, your compensation and any of your acquisitions and dispositions of stock of the Company may in the
future be subject to Securities Exchange Commission reporting rules. 
 The following outlines the employment package for your position. 

START DATE: June 25, 2018 or earlier. 
 POSITION: Executive
Vice President, Chief Operating Officer. Your responsibilities will be those outlined in your job description, as may be modified, and as may be assigned to you from time to time by the President and CEO. You will also be required, as appropriate
and consistent with other senior executives, to attend and participate in (i) necessary senior executive meetings, committees and councils and (ii) meetings of the Board of Directors of the Company. 

COMPENSATION: Your position is classified as a salaried exempt position, which means it is exempt from state and federal overtime laws. You will be paid a bi-weekly base salary of $13,461.54, which is equivalent to $350,000 per year, subject to normal withholdings and payroll taxes. You will not be entitled to any additional compensation in the event you are
appointed to serve as an officer or director of any of the Company’s direct or indirect subsidiaries 
 or affiliates. 

RLH Corporation 1550 Market Street, Denver CO 80202     rlhco.com     franchise.rlhco.com
    509-459-6100 

 BONUS: In addition to your base salary, you are eligible to earn a bonus if you are actively employed throughout
the applicable bonus period, and if you meet the other requirements outlined in any bonus plan as may be approved by the Company from time to time for Executive Vice Presidents of the Company. Bonus targets and goals for achievement of bonuses by
executive officers are set by the Compensation Committee of the Board. Bonus targets for this position are set for 2018 at 60% of base salary. Any bonus earned by you in 2018 would be prorated for the portion of the year you are employed by the
Company. 
 EQUITY GRANT: At the sole discretion of the Compensation Committee of the Company’s Board, you will receive an annual grant of equity under
the Company’s 2015 Stock Incentive Plan (or such successor plan as may be then in effect). Subject to such discretion, such grant shall be in a value equal to 80% of your base salary, a portion of which shall be is anticipated to be issued
in the form of restricted stock units (“RSUs”) vesting 25% on each of the first four anniversaries of issuance, and the balance of which is anticipated be issued in the form of performance stock units (“PSUs”) vesting in
accordance with performance metrics to be determined by the Compensation Committee in its sole discretion and consistent with the terms and conditions of PSUs issued to the Company’s other executive officers. In addition, you will receive
88,000 Restricted Stock Units in the Company vesting entirely on the fourth (4th) anniversary of your Start Date, 25% on each of the first four anniversaries of issuance. Any such vested RSUs
shall be settled exclusively in the common stock of the Company. 
 RELOCATION: We will reimburse you for approved relocation costs in accordance with our
policies for such reimbursements in a reasonable amount to be mutually agreed. In the event you voluntarily terminate your employment with the Company prior to the first anniversary of your Start Date, you will be required to reimburse to the
Company any amount the Company has paid your for relocation costs and you authorize the Company to deduct the entire amount from your final paycheck or from any other funds the Company then owes to you or is holding on your behalf. Should the
amount exceed your final paycheck and other funds the Company then owes you, you agree to promptly reimburse the Company any remaining balance at that time. 

BENEFITS: You will be eligible to participate in all employee benefit programs on the same terms and conditions as any Company Executive Vice President, as
they may be modified from time to time, including: 
  

	 	•	 	Medical and Dental insurance eligible the first of the month following your Start Date 

  

	 	•	 	Employee Assistance Program (EAP) 

  

	 	•	 	Long Term Disability insurance coverage starting the first of the month following your Start Date 

	 	•	 	Flexible Spending Account—Section 125 Medical Reimbursement and Dependent Care accounts eligible within 30 days of your Start Date for the following 1st of
the month effective date 

  

	 	•	 	AFLAC—Voluntary Cancer Protection, Short Term Disability, Personal Recovery and Accident / Injury Protection Plans available following Start Date and also during open enrollment periods 

 

	 	•	 	Vacation, Holiday, Sick Pay and Disability Programs 

  

	 	•	 	Participation in the Company 401(k) Retirement Savings Plan with a discretionary match made after the end of each calendar year. 

  

	 	•	 	Direct Deposit 

  

	 	•	 	Option to purchase shares of Company stock at a 15% discount through payroll deduction under Red Lion’s Employee Stock Purchase Plan 

 

	 	•	 	Voluntary Term Life and AD&D Insurance coverage eligible the first of the month following your Start Date 

  

	 	•	 	Continuing education reimbursement 

  

	 	•	 	Discounted hotel accommodations for you and your family at Company hotels 

 A benefit book will be provided to
you upon the commencement of your employment, describing the Company’s benefits and eligibility requirements in detail. You will also receive a copy of the Company’s Associate Handbook with information regarding the Company’s policies
and procedures. 
 SEVERANCE BENEFITS: 
 UPON TERMINATION
WITHOUT CAUSE: If the Company terminates your employment without Cause (defined below), the Company will pay you a lump sum payment equal to one-half (1/2) your base annual salary for the then current fiscal
year, provided that as a previous condition to such payment, you shall execute and not revoke during any legally applicable revocation period, a mutually acceptable separation agreement and general release. 

UPON CHANGE OF CONTROL AND CONSTRUCTIVE TERMINATION: If, during the term of your employment with the Company, there is a Change of Control (defined below) and
there is a Constructive Termination (defined below) of your employment without Cause within twelve (12) months after such Change of Control, you will, in lieu of severance under the preceding paragraph, be entitled to a lump sum payment equal
to the sum of (a) your base annual salary for the then current fiscal year, plus (b) an amount equal to (i) your target annual bonus under the then applicable bonus plan for the then current fiscal year, multiplied by (ii) a
fraction, the numerator 

 
of which is 365 plus the number of days elapsed in the then current fiscal year at the time of the termination and the denominator of which is 365. In addition, (A) the Company shall
accelerate vesting on any portion of any equity grant previously made to you under the Company’s 2015 Stock Incentive Plan, or any successor plan, that would otherwise have vested after the date of the termination of your employment; and
(B) all Company imposed restrictions under any restricted stock, restricted stock unit or other similar equity-based awards granted to you by the Company shall be terminated upon the termination of your employment, and the Company shall issue
all common stock that underlies such awards but has not yet been issued; provided that (i) if the terms of any such award require you to pay monetary consideration for such stock, the stock underlying such award shall be issued only if you pay
such consideration, and (ii) if any restrictions under any such award are performance-based, such restrictions shall terminate and the stock underlying such award shall be issued only if and to the extent expressly provided in the agreement
evidencing the award. 
 As used herein, the term “Cause” means: (i) your willful and intentional failure or refusal to perform or observe
any of your material duties, responsibilities or obligations, if such breach is not cured within 30 days after notice thereof to you by the Company, which notice shall state that such conduct shall, without cure, constitute Cause; (ii) any
willful and intentional act by you involving fraud, theft, embezzlement or dishonesty affecting the Company; or (iii) your conviction of (or a plea of nolo contendere to) an offense which is a felony in the jurisdiction involved. 

“Constructive Termination” shall be deemed to occur if the Company terminates your employment without Cause, or if you voluntarily elect to
terminate your employment within thirty (30) days after any of the following events occurring without your consent: (i) there is a significant reduction in your overall scope of duties, authorities and responsibilities (it being understood
that a new position within a larger combined company is not a constructive termination if it is in the same area of operations and involves similar scope of management responsibility notwithstanding that you may not retain as senior a position
overall within the larger combined company as your prior position within the Company); or (ii) there is a reduction of more than 20% of your base salary or target bonus (other than any such reduction consistent with a general reduction of pay
across the Company’s or its successor’s executive staff as a group, as an economic or strategic measure due to poor financial performance by the Company). 

As used herein, the term “Change of Control” means the occurrence of any one of the following events: any merger or consolidation involving the
acquisition of 50% or more of the combined voting power of the outstanding securities of the Company by a “person” or “group” (as those terms are defined in Sections 13(d) and 14(d) of the Securities Exchange Act of
1934), adoption 

 
of a plan for liquidation of the Company or for sale of all or substantially all of the assets of the Company or other similar transaction or series of transactions involving the Company, or the
acquisition of 50% or more of the combined voting power of the outstanding securities of the Company by a “person” or “group” (as those terms are defined in Sections 13(d) and 14(d) of the Securities Exchange Act of
1934). 
 The severance amounts hereunder shall, subject to COMPLIANCE WITH SECTION 409A below, be paid to you as soon as practicable following the
occurrence of the event that entitles you to such payments. 
 COMPLIANCE WITH SECTION 409A: Notwithstanding any other provision of this letter to the
contrary, the provision, time and manner of payment or distribution of all compensation and benefits provided by this letter (“Section 409A Deferred Compensation”) that constitute nonqualified deferred compensation subject to and not
exempted from the requirements of Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), shall be subject to, limited by and construed in accordance with the requirements of such section and all regulations and
other guidance promulgated by the Secretary of the Treasury pursuant to such section (such section, regulations and other guidance being referred to herein as “Section 409A”), including the following: 

(a) Separation from Service. Payments and benefits constituting Section 409A Deferred Compensation otherwise payable or provided pursuant to this
letter upon your Constructive Termination shall be paid or provided only at the time of a termination of your employment that constitutes a Separation from Service. For the purposes of this letter, a “Separation from Service” is a
separation from service within the meaning of Treasury Regulation Section 1.409A-1(h). 
 (b) Six-Month Delay Applicable to Specified Employees. If, at the time of your Separation from Service, you are a “specified employee” within the meaning of Section 409A(a)(2)(B)(i) of the Code, then
any payments and benefits constituting Section 409A Deferred Compensation to be paid or provided pursuant to this letter upon your Separation from Service shall be paid or provided commencing on the later of (i) the first business day
after the date that is six months after the date of such Separation from Service or, if earlier, the date of your death (in either case, the “Delayed Payment Date”), or (ii) the date or dates on which such Section 409A Deferred
Compensation would otherwise be paid or provided in accordance with this letter without regard to this paragraph. All such payments and benefits that would, but for this paragraph, become payable prior to the Delayed Payment Date shall be
accumulated and paid on the Delayed Payment Date. 

 (c) Installments. Your right to receive any amounts payable hereunder in two or more installments shall be
treated as a right to receive a series of separate payments and, accordingly, each such installment payment shall at all times be considered a separate and distinct payment for purposes of Section 409A. 

(d) Notice Upon Constructive Termination. If you voluntarily elect to terminate your employment under circumstances that would otherwise constitute a
Constructive Termination under this letter, a Constructive Termination shall not be deemed to have occurred unless (i) you have given the Company written notice that a specified event has occurred giving you the right to voluntarily terminate
your employment and have that be treated as a Constructive Termination, (ii) the Company fails to cure such event within a period of thirty (30) days after the receipt of such notice, and (iii) you voluntarily terminate your
employment within thirty (30) days following the end of that period. 
 PROOF OF ELIGIBILITY TO WORK IN U.S.: Our offer is contingent upon your
submission of satisfactory proof of your identity and your legal authorization to work in the United States. If you fail to submit this proof, federal law prohibits us from hiring you. 

LOYALTY, NONDISCLOSURE OF CONFIDENTIAL INFORMATION: By accepting this offer, you agree that you will act at all times in the best interest of the Company. You
also agree that, except as required for performance of your work, you will not use, disclose or publish any Confidential Information of the Company either during or after your employment, or remove any such information from the Company’s
premises. Confidential Information includes, but is not limited to, lists of actual and prospective customers and clients, financial and personnel-related information, projections, operating procedures, budgets, reports, business or marketing plans,
compilations of data created by the Company or by third parties for the benefit of the Company. 
 NONCOMPETITION AND NONSOLICITATION: (a) You agree
that during a period after termination of your employment commensurate with the months of base salary you are paid as a benefit in connection with a related severance event, you will not, directly or indirectly, engage or participate or make any
financial investments in (other than ownership of up to 5% of the aggregate of any class of securities of any corporation if such securities are listed on a national stock exchange or under section 12(g) of the Securities Exchange Act of 1934) or
become employed by, or act as an agent or principal of, or render advisory or other management services to or for, any Competing Business. As used herein the term “Competing Business” means any business which includes hotel ownership,
hotel management, hotel services or hotel franchising that competes directly or indirectly with the Company. 

 (b) You also agree that during your employment at the Company and during a period after termination of your
employment commensurate with the months of base salary you are paid as a benefit in connection with a related severance event, you will not solicit, raid, entice or induce any person that then is or at any time during the twelve-month period prior
to the end of your employment was an employee of the Company (other than a person whose employment with the Company has been terminated by the Company), to become employed by any person, firm or corporation. 

COMPLAINT RESOLUTION: By accepting this offer with the Company, you also agree to continue to familiarize yourself with its policies, including its policies
on equal opportunity and anti-harassment, and to promptly report to the appropriate the Company supervisors or officers any matters which require their attention. 

KEY EMPLOYEE STATUS: You are regarded as a key employee under certain federal regulations governing family and medical leave. This status will require that
you work closely with us in planning if you develop a need for family or medical leave. 
 NATURE OF EMPLOYMENT: As explained to you on the application for
employment you submitted, the Company is an at-will employer. This means that your employment is not for a set amount of time; either you or the Company may terminate employment at any time, with or without
cause. 
 BACKGROUND CHECK: The Company has a vital interest in maintaining safe, lawful and efficient working conditions for its employees. With this in
mind, employment at the Company is contingent on your satisfactory completion of a background check. 
 ENTIRE AGREEMENT: This letter contains all of the
terms of your employment with the Company, and supersedes any prior understandings or agreements, whether oral or in writing. 
 The Company reserves the
right, subject to limitations and provisions of applicable law and regulations, to change, interpret, withdraw, or add to any of its policies, benefits, or terms and conditions of employment at its sole discretion, and without prior notice or
consideration to any associate. The Company’s policies, benefits or terms and conditions of employment do not create a contract or make any promises of specific treatment. 

 We are pleased and proud to be adding your talents to a leadership team that is dedicated to making a difference
in the communities we serve, creating fulfilling jobs and environments conducive to success, and providing the foundation for ongoing success of the Company. 
  

	
	Sincerely,
	
	/s/ Gregory T. Mount
	Gregory T. Mount

 President and CEO 
 Red Lion
Hotels Corporation 
 Accepted as of the date first set forth above: 

	
	
	/s/ Gary L. Sims

 Gary L. SimsPLACEMENT
AGENCY AGREEMENT

 

between

 

GREENPRO
CAPITAL CORP.

 

(a
Nevada Corporation)

 

and

 

NETWORK
1 FINANCIAL SECURITIES, INC.

 

as
Placement Agent

 

    	 

     

    

 

GREENPRO
CAPITAL CORP.

Minimum
Offering: $3,000,000

Maximum
Offering: $15,000,000

($6.00
per share)

PLACEMENT
AGENCY AGREEMENT

 

May
31, 2018

 

Network
1 Financial Securities, Inc.

2
Bridge Avenue, Penthouse

Red
Bank, NJ 07701

 

Ladies
and Gentlemen:

 

This
letter (this “Agreement”) constitutes the agreement between Greenpro Capital Corp., a Nevada corporation
(collectively with its subsidiaries and affiliates, including, without limitation, all entities disclosed or described in the
Registration Statement (as hereinafter defined) as being subsidiaries or affiliates of the Company, the “Company”)
and Network 1 Financial Securities, Inc. (the “Placement Agent”) pursuant to which the Placement Agent
shall serve as the Placement Agent (the “Services”) for the Company, on a reasonable “best efforts”
basis, in connection with the proposed offer (the “Offering”) by the Company of its Securities (as defined
in Section 3 of this Agreement).

 

The
Placement Agent will act on a reasonable “best efforts” basis with a minimum offering amount of 500,000 Shares (the
aggregate proceeds from the amount of the 500,000 Shares is referred to as the “Minimum Amount”) and a maximum
offering amount of 2,500,000 Shares at a purchase price of $6.00 per Share (the aggregate proceeds from the amount of 2,500,000
Shares is referred to as the “Maximum Amount”), and the Company agrees and acknowledges that there is no guarantee
of the successful placement of the Shares, or any portion thereof, in the prospective Offering. No Closing (as defined in Section
2.1 of this agreement) will occur unless the Minimum Amount has been subscribed.

 

1.
Appointment of Placement Agent.

 

On
the basis of the representations, warranties, covenants and agreements of the Company herein contained, and subject to all the
terms and conditions of this Agreement, the Company hereby appoints the Placement Agent as its exclusive Placement Agent in connection
with a distribution of its Securities to be offered and sold by the Company pursuant to a registration statement filed under the
Securities Act of 1933, as amended (the “Securities Act”) on Form S-1 (File No. 333-219625), and the Placement
Agent agrees to act as the Company’s exclusive Placement Agent. Pursuant to this appointment, the Placement Agent will solicit
offers for the purchase of or attempt to place all or part of the Securities of the Company in the proposed Offering. Until the
final closing or earlier upon termination of this Agreement pursuant to Section 5 hereof, the Company shall not, without the prior
written consent of the Placement Agent, solicit or accept offers to purchase the Securities other than through the Placement Agent.
The Company acknowledges that the Placement Agent will act as agent of the Company and use their reasonable “best efforts”
to solicit offers to purchase the Securities from the Company on the terms, and subject to the conditions, set forth in the Prospectus
(as defined below). The Placement Agent shall use commercially reasonable efforts to assist the Company in obtaining performance
by each Purchaser whose offer to purchase Securities has been solicited by the Placement Agent, but the Placement Agent shall
not, except as otherwise provided in this Agreement, be obligated to disclose the identity of any potential purchaser or have
any liability to the Company in the event any such purchase is not consummated for any reason. Under no circumstances will the
Placement Agent be obligated to underwrite or purchase any Securities for its own account and, in soliciting purchases of the
Securities, the Placement Agent shall act solely as an agent of the Company. The Services provided pursuant to this Agreement
shall be on an “agency” basis and not on a “principal” basis.

 

The
Placement Agent will solicit offers for the purchase of the Securities in the Offering at such times and in such amounts as the
Placement Agent deems advisable. The Company shall have the sole right to accept offers to purchase Securities and may reject
any such offer, in whole or in part. The Placement Agent may retain other brokers or dealers to act as sub-agent on their behalf
in connection with the Offering and may pay any sub-agent a solicitation fee with respect to any Securities placed by it.

 

    	 

     

    

 

2.
Fees; Expenses; Other Arrangements.

 

2.1. Placement Agent’s Fee. As
compensation for services rendered, the Company shall pay to the Placement Agent in cash by wire transfer in immediately available
funds to an account or accounts designated by the Placement Agent an amount equal to 5% of the aggregate gross proceeds received
by the Company from the sale of the Securities at each closing (each a “Closing” and each date on which a Closing
occurs, the “Closing Date”); a non-accountable expense allowance equal to 1.5% of the gross proceeds received
by the Company from the sale of the Securities; and the Company shall issue to the Placement Agent or its designees at the Closing
five-year warrants to purchase a number of shares equal to an aggregate of 10% of the aggregate number of shares sold in this
Offering at an exercise price of $7.20 (the “Placement Agent’s Warrants” and together with the
shares of Common Stock (as defined below) underlying such warrants, the “Placement Agent Securities”).

 

2.2.
Offering Expenses. The Company hereby agrees to pay on the Closing Date all expenses incident to the preparation of, and
performance of the obligations of, the Company under this Agreement including, but not limited to: (a) all filing fees relating
to the registration of the shares to be sold in the Offering with the Commission; (b) all COBRADesk filing fees associated with
the review of the Offering by FINRA; (c) all fees and expenses relating to the listing of such shares on the Nasdaq and such other
stock exchanges as the Company and the Placement Agent together determine; (d) all fees, expenses and disbursements relating to
the registration, qualification or exemption of such Shares under the securities laws of such states and foreign jurisdictions
as the Placement Agent may reasonably designate, if applicable; (e) the costs of all mailing and printing of the offering documents,
Registration Statements, Prospectuses and all amendments, supplements and exhibits thereto and as many preliminary and final Prospectuses
as the Placement Agent may reasonably deem necessary, (f) the costs of preparing, authenticating, issuing, printing and delivering
certificates representing the Shares; (g) fees and expenses of the Depositary for the Shares; (h) stock transfer and/or stamp
taxes, if any, payable upon the transfer of securities from the Company to the Placement Agent; (i) the fees and expenses of the
Company’s accountants; (j) the fees and expenses of the Company’s legal counsel and other agents; (k) the costs associated
with post-Closing advertising of the Offering in the national editions of the Wall Street Journal and New York Times except that
that Company shall only reimburse the Placement Agent for the costs of this subsection (l) if the Company gives its prior written
consent to such advertisements; and (m) actual “road show” expenses for the Offering incurred by the Company. The
Placement Agent may also deduct from the net proceeds of the Offering payable to the Company on the Closing Date the expenses
set forth herein to be paid by the Company to the Placement Agent. Such expenses shall include reimbursement of up to $100,000
of the Placement Agent’s actual expenses including but not limited to (a) reasonable travel and out-of-pocket expense in
connection with the Offering; (b) reasonable fees and expenses of legal counsel incurred by the Placement Agent in connection
with the Offering; (c) the cost of due diligence meetings not exceeding $10,000 in the aggregate; and (d) preparation of printed
documents for closing and deal mementos with costs not exceeding US$3,000. Any remaining costs and expenses of the Placement Agent
shall be borne by the Placement Agent. The Placement Agent acknowledges that $70,000 of this allowance has been paid by the Company
and shall be deducted from the accountable expense allowance payable pursuant to this Section 2.2.1.

 

3.
Description of the Offering.

 

The
Securities to be offered directly to various investors (each, an “Investor” or “Purchaser”
and, collectively, the “Investors” or the “Purchasers”) in the Offering shall be a minimum
of 500,000 Shares and a maximum offering amount of 2,500,000 Shares (the “Common Stock” or “Shares”).
The Shares to be offered in the Offering shall be referred to as the “Securities”. The purchase price for one
Share shall be $6.00 (the “Share Purchase Price”). If the Company shall default in its obligations to deliver
Securities to a Purchaser whose offer it has accepted and who has tendered payment, the Company shall indemnify and hold the Placement
Agent harmless against any loss, claim, damage or expense arising from or as a result of such default by the Company under this
Agreement.

 

    	 

     

    

 

4.
Delivery and Payment; Closing.

 

Settlement
of the Securities purchased by an Investor shall be made by 5:00 p.m. Eastern time, on the Closing Date by wire transfer in federal
(same day) funds, payable to the order of the Company after delivery of the certificates (in form and substance satisfactory to
the Placement Agent) or via electronic delivery. On the Closing Date, the Common Stock to which the Closing relates shall be delivered
via The Depository Trust Company Deposit or Withdrawal at Custodian (DWAC) system for the accounts of the Placement Agent or as
otherwise designated by the Placement Agent. The Securities shall be registered in such name or names and in such authorized denominations
as the Placement Agent may request in writing at least one Business Day prior to the Closing Date. The term “Business
Day” means any day other than a Saturday, a Sunday or a legal holiday or a day on which banking institutions are authorized
or obligated by law to close in New York, New York.

 

The
Closing shall occur at such place as shall be agreed upon by the Placement Agent and the Company. In the absence of an agreement
to the contrary, each Closing shall take place at the offices of Mei & Mark LLP, 818 18th Street NW, Suite 410, Washington,
DC 20006. Deliveries of the documents with respect to the purchase of the Securities, if any, shall be made at the offices of
Mei & Mark LLP, 818 18th Street, NW, Suite 410, Washington, DC 20006 on the Closing Date. All actions taken at a Closing shall
be deemed to have occurred simultaneously.

 

5.
Term and Termination of Agreement.

 

The
term of this Agreement will commence upon the execution of this Agreement and will terminate at the earlier of the Closing of
the Offering or 11:59 p.m. Eastern time on June 30, 2018, unless extended by mutual agreement of the Company and the Placement
Agent. Notwithstanding anything to the contrary contained herein, any provision in this Agreement concerning or relating to confidentiality,
indemnification, contribution, advancement, the Company’s representations and warranties and the Company’s obligations
to pay fees and reimburse expenses will survive any expiration or termination of this Agreement. If any condition specified in
Section 8 is not satisfied when and as required to be satisfied, this Agreement may be terminated by the Placement Agent by notice
to the Company at any time on or prior to a Closing Date, which termination shall be without liability on the part of any party
to any other party, except that those portions of this Agreement specified in Section 19 shall at all times be effective and shall
survive such termination. Notwithstanding anything to the contrary in this Agreement, in the event that this Agreement shall not
be carried out for any reason whatsoever, within the time specified herein or any extensions thereof pursuant to the terms herein,
the Company shall be obligated to pay to the Placement Agent its actual and accountable out-of-pocket expenses as provided for
in Section 2.2. above and upon demand the Company shall pay the full amount thereof to the Placement Agent.

 

6.
Permitted Acts.

 

Nothing
in this Agreement shall be construed to limit the ability of the Placement Agent, its officers, directors, employees, agent, associated
persons and any individual or entity “controlling,” “controlled by,” or “under common control”
with the Placement Agent (as those terms are defined in Rule 405 under the Securities Act) to conduct its business including without
limitation the ability to pursue, investigate, analyze, invest in, or engage in investment banking, financial advisory or any
other business relationship with any individual or corporation, partnership, trust, incorporated or unincorporated association,
joint venture, limited liability company, joint stock company, government (or an agency or subdivision thereof) or other entity
of any kind.

 

7.
Representations, Warranties and Covenants of the Company.

 

As
of the date and time of the execution of this Agreement, the Closing Date and the Initial Sale Time (as defined herein), the Company
represents, warrants and covenants to the Placement Agent, other than as disclosed in any of its filings with the Securities and
Exchange Commission (the “Commission”), that:

 

    	 

     

    

 

7.1
Registration Matters.

 

7.1.1.
The Company has filed with the Commission a registration statement on Form S-1 (File No. 333-219625) including a related prospectus
for the registration of the Common Stock and the Placement Agent Securities under the Securities Act, and the rules and regulations
thereunder (the “Securities Act Regulations”) and a post-effective amendment to the registration statement.
The registration statement and the post-effective amendment to the registration statement have been declared effective under the
Securities Act by the Commission. The “Registration Statement,” as of any time, means such registration statement
as amended by any post-effective amendments thereto at such time, including the exhibits and any schedules thereto at such time,
the documents incorporated or deemed to be incorporated by reference therein at such time under the Securities Act and the documents
otherwise deemed to be a part thereof as of such time pursuant to Rule 430A (“Rule 430A”) or Rule 430B under
the Securities Act Regulations (“Rule 430B”); provided, however, that the “Registration Statement”
without reference to a time means such registration statement as amended by any post-effective amendments thereto as of the time
of the first contract of sale for the Securities, which time shall be considered the “new effective date” of such
registration statement with respect to the Securities within the meaning of paragraph (f)(2) of Rule 430B, including the exhibits
and schedules thereto as of such time, the documents incorporated or deemed incorporated by reference therein at such time pursuant
the Securities Act and the documents otherwise deemed to be a part thereof as of such time pursuant to the Rule 430A or Rule 430B.
Any registration statement filed pursuant to Rule 462(b) of the Securities Act Regulations is hereinafter called the “Rule
462(b) Registration Statement,” and after such filing the term “Registration Statement” shall include the
Rule 462(b) Registration Statement. The prospectus set forth in the Registration Statement in the form first used to confirm sales
of the Securities (or in the form first made available to the Placement Agent by the Company to meet requests of purchasers pursuant
to Rule 173 under the Securities Act), is hereinafter referred to, collectively, as the “Prospectus,” and the
term “Preliminary Prospectus” means the preliminary form of the Prospectus dated April 30, 2018.

 

7.1.2.
All references in this Agreement to financial statements and schedules and other information which is “contained,”
“included” or “stated” (or other references of like import) in the Registration Statement, any Preliminary
Prospectus or the Prospectus shall be deemed to include all such financial statements and schedules and other information set
forth in or, if applicable, incorporated or deemed incorporated by reference in the Registration Statement, such Preliminary Prospectus
or the Prospectus, as the case may be, prior to the execution and delivery of this Agreement; and all references in this Agreement
to amendments or supplements to the Registration Statement, any Preliminary Prospectus or the Prospectus shall be deemed to include
the filing of any document under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and
the rules and regulations thereunder (the “Exchange Act Regulations”), incorporated or deemed to be incorporated
by reference in the Registration Statement, such Preliminary Prospectus or the Prospectus, as the case may be, at or after the
execution and delivery of this Agreement.

 

7.1.3.
The term “Disclosure Package” means (i) the Prospectus, as most recently amended or supplemented immediately
prior to the Initial Sale Time (as defined herein), (ii) the Issuer Free Writing Prospectuses (as defined below), if any, identified
in Exhibit B hereto, and (iii) any other Free Writing Prospectus (as defined below) that the parties hereto shall hereafter expressly
agree to treat as part of the Disclosure Package.

 

7.1.4.
The term “Issuer Free Writing Prospectus” means any issuer free writing prospectus, as defined in Rule 433
of the Securities Act Regulations. The term “Free Writing Prospectus” means any free writing prospectus, as
defined in Rule 405 of the Securities Act Regulations.

 

7.1.5.
Any Preliminary Prospectus when filed with the Commission, and the Registration Statement as of each effective date and as of
the date hereof, complied or will comply, and the Prospectus and any further amendments or supplements to the Registration Statement,
any Preliminary Prospectus or the Prospectus will, when they become effective or are filed with the Commission, as the case may
be, comply, in all material respects, with the requirements of the Securities Act and the Securities Act Regulations; and, if
applicable, the documents incorporated by reference in the Registration Statement, any Preliminary Prospectus or the Prospectus
complied, and any further documents so incorporated will comply, when filed with the Commission, in all material respects to the
requirements of the Exchange Act and Exchange Act Regulations.

 

7.1.6.
The issuance by the Company of the Securities and Placement Agent Securities has been registered under the Securities Act. The
Securities and Placement Agent Securities will be issued pursuant to the Registration Statement and each of the Securities and
Placement Agent Securities will be freely transferable and freely tradable by each of the Investors or the Placement Agent, as
applicable, without restriction, unless otherwise restricted by applicable law or regulation.

 

    	 

     

    

 

7.2
Stock Exchange Listing. The Shares have been approved for listing on Nasdaq Capital Market (the “Exchange”)
and the Company has taken no action designed to, or likely to have the effect of, delisting the shares of Common Stock from the
Exchange, nor has the Company received any notification that the Exchange is contemplating terminating such listing.

 

7.3
No Stop Orders, etc. Neither the Commission nor, to the Company’s knowledge, any state regulatory authority has issued
any order preventing or suspending the use of the Registration Statement, any Preliminary Prospectus or the Prospectus or has
instituted or, to the Company’s knowledge, threatened to institute, any proceedings with respect to such an order. The Company
has complied with each request (if any) from the Commission for additional information.

 

7.4
Subsidiaries. The Company does not own or control, directly or indirectly, any corporation, association or other entity
other than the subsidiaries (collectively, the “Subsidiaries” and each a “Subsidiary”) and
the variable interest entity (the “VIE”) listed on Exhibit 21.1 to the Registration Statement. The Subsidiaries
and the VIE are herein collectively called the “Group Entities” and each of them is herein called a “Group
Entity.” Each Group Entity has been duly organized and is validly existing as a corporation in good standing under the
laws of the jurisdiction of its incorporation, has corporate power and authority to own, lease and operate its properties and
to conduct its business as described in the Registration Statement, the Disclosure Package and the Prospectus and is duly qualified
as a foreign corporation to transact business and is in good standing in each jurisdiction in which such qualification is required,
whether by reason of the ownership or leasing of property or the conduct of business, except where the failure so to qualify or
to be in good standing would not result in a Material Adverse Change (as hereinafter defined); except as otherwise disclosed in
the Registration Statement, the Disclosure Package and the Prospectus, all of the issued and outstanding capital stock of each
Subsidiary has been duly authorized and validly issued, is fully paid and non-assessable and is owned by the Company, directly
or through the Subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance, claim or equity; except
as otherwise disclosed in the Registration Statement, the Disclosure Package and the Prospectus, all of the issued and outstanding
capital stock of each VIE has been duly authorized and validly issued, is fully paid and non-assessable and is owned by Loke Che
Chan, Gilbert and Lee Chong Kuang directly or through the VIEs, free and clear of any security interest, mortgage, pledge, lien,
encumbrance, claim or equity; none of the outstanding shares of capital stock of any Group Entity was issued in violation of the
preemptive or similar rights of any security holder of such Group Entity. The constitutive documents of each of the Group Entities
comply with the requirements of applicable law in their respective jurisdictions of incorporation and are in full force and effect.
Unless otherwise set forth, all references in this Section 7 to the “Company” shall include references to all of the
Company’s Subsidiaries and VIEs.

 

7.5
Disclosures in Registration Statement.

 

7.5.1
Compliance with Securities Act and 10b-5 Representation

 

(i)
Each of the Registration Statement and any post-effective amendment thereto, at the time it became effective, complied in all
material respects with the requirements of the Securities Act and the Securities Act Regulations. The Preliminary Prospectus and
the Prospectus, at the time each was filed with the Commission, complied in all material respects with the requirements of the
Securities Act and the Securities Act Regulations. The Preliminary Prospectus delivered to the Placement Agent for use in connection
with this Offering and the Prospectus was or will be identical to the electronically transmitted copies thereof filed with the
Commission pursuant to EDGAR, except to the extent permitted by Regulation S-T.

 

(ii)
Neither the Registration Statement nor any amendment thereto, at its effective time, as of 4:30 p.m. (Eastern time) on the date
of this Agreement (the “Initial Sale Time”),and at the Closing Date, contained, contains or will contain an untrue
statement of a material fact or omitted, omits or will omit to state a material fact required to be stated therein or necessary
to make the statements therein not misleading; provided, however, that this representation and warranty shall not apply to statements
made or statements omitted in reliance upon and in conformity with written information furnished to the Company with respect to
the Placement Agent by the Placement Agent expressly for use in the Registration Statement or any amendment thereof or supplement
thereto. The parties acknowledge and agree that such information provided by or on behalf of any Placement Agent consists solely
of the following disclosure contained in the following paragraphs in the “Plan of Distribution” section of the Prospectus:
(i) the name of the Placement Agent, and (ii) the information under the subsection “Fees and Expenses” (the “Placement
Agent’s Information”)

 

    	 

     

    

 

(iii)
The Disclosure Package, as of the Initial Sale Time and at the Closing Date, did not, does not and will not include an untrue
statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light
of the circumstances under which they were made, not misleading; and each Issuer Free Writing Prospectus does not conflict with
the information contained in the Registration Statement, any Preliminary Prospectus, or the Prospectus, and each such Issuer Free
Writing Prospectus, as supplemented by and taken together with the Preliminary Prospectus as of the Initial Sale Time, did not
include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein,
in light of the circumstances under which they were made, not misleading; and

 

(iv)
Neither the Prospectus nor any amendment or supplement thereto, as of its issue date, at the time of any filing with the Commission
pursuant to Rule 424(b), at the Closing Date, included, includes or will include an untrue statement of a material fact or omitted,
omits or will omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances
under which they were made, not misleading; provided, however, that this representation and warranty shall not apply to the Placement
Agent’s Information.

 

7.5.2
Disclosure Agreements. The agreements and documents described in the Registration Statement, the Disclosure Package and
the Prospectus conform in all material respects to the descriptions thereof contained therein and there are no agreements or other
documents required by the Securities Act and the Securities Act Regulations to be described in the Registration Statement, the
Disclosure Package and the Prospectus or to be filed with the Commission as exhibits to the Registration Statement, that have
not been so described or filed. Each agreement or other instrument (however characterized or described) to which the Company is
a party or by which it is or may be bound or affected and (i) that is referred to in the Registration Statement, the Disclosure
Package and the Prospectus, and (ii) is material to the Company’s business, has been duly authorized and validly executed
by the Company, is in full force and effect in all material respects and is enforceable against the Company and, to the Company’s
knowledge, the other parties thereto, in accordance with its terms, except (x) as such enforceability may be limited by bankruptcy,
insolvency, reorganization or similar laws affecting creditors’ rights generally, (y) as enforceability of any indemnification
or contribution provision may be limited under the federal and state securities laws, and (z) that the remedy of specific performance
and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the discretion of the court
before which any proceeding therefor may be brought. None of such agreements or instruments has been assigned by the Company,
and neither the Company nor, to the Company’s knowledge, any other party is in default thereunder and, to the Company’s
knowledge, no event has occurred that, with the lapse of time or the giving of notice, or both, would constitute a default thereunder,
except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus. To the Company’s knowledge,
performance by the Company of the material provisions of such agreements or instruments will not result in a violation of any
existing applicable law, rule, regulation, judgment, order or decree of any governmental agency or court, domestic or foreign,
having jurisdiction over the Company or any of its assets or businesses (each, a “Governmental Entity”), including,
without limitation, those relating to environmental laws and regulations.

 

7.5.3
Prior Securities Transactions. Since the beginning of the period covered by the financial statement included in the Registration
Statement, no securities of the Company have been sold by the Company or by or on behalf of, or for the benefit of, any person
or persons controlling, controlled by or under common control with the Company, except as disclosed in the Registration Statement,
the Disclosure Package and the Preliminary Prospectus.

 

7.5.4
Regulations. The disclosures in the Registration Statement, the Disclosure Package and the Prospectus concerning the effects
of federal, state, local and all foreign regulation on the Offering and the Company’s business as currently contemplated
are correct in all material respects and no other such regulations are required to be disclosed in the Registration Statement,
the Disclosure Package and the Prospectus, which are not so disclosed.

 

7.5.5
Changes After Dates in Registration Statement.

 

(i)
No Material Adverse Change. Since the respective dates as of which information is given in the Registration Statement,
the Disclosure Package and the Prospectus, except as otherwise specifically stated therein: (i) there has been no material adverse
change in the financial position or results of operations of the Company, nor any change or development that, singularly or in
the aggregate, would involve a material adverse change or a prospective material adverse change, in or affecting the condition
(financial or otherwise), results of operations, business, assets or prospects of the Company (a “Material Adverse Change”);
(ii) there have been no material transactions entered into by the Company, other than as contemplated pursuant to this Agreement;
and (iii) no officer or director of the Company has resigned from any position with the Company.

 

    	 

     

    

 

(ii)
Recent Securities Transactions, etc. Subsequent to the respective dates as of which information is given in the Registration
Statement, the Disclosure Package and the Prospectus, and except as may otherwise be indicated or contemplated herein or disclosed
in the Registration Statement, the Disclosure Package and the Prospectus, the Company has not: (i) issued any securities (other
than (i) grants under any stock compensation plan and (ii) shares of common stock issued upon exercise or conversion of option,
warrants or convertible securities described in the Registration Statement, the Disclosure Package and the Prospectus) or incurred
any liability or obligation, direct or contingent, for borrowed money; or (ii) declared or paid any dividend or made any other
distribution on or in respect to its capital stock.

 

7.6
Independent Accountants. To the knowledge of the Company, Weinberg & Company, during such time as the firm was engaged
by the Company (collectively, the “Auditors”), was an independent registered public accounting firm as required
by the Securities Act and the Securities Act Regulations and the Public Company Accounting Oversight Board. During such time period
in which the Auditors served as the Company’s independent registered public accounting firm the Auditors did not or have
not, during the periods covered by the financial statements included in the Registration Statement, the Disclosure Package and
the Prospectus, provided to the Company any non-audit services, as such term is used in Section 10A(g) of the Exchange Act.

 

7.7
SEC Reports; Financial Statements, etc. The Company has complied in all material respects with requirements to file all
reports, schedules, forms, statements and other documents required to be filed by it under the Securities Act and the Exchange
Act, including pursuant to Section 13(a) or 15(d) thereof (the foregoing materials, including the exhibits thereto and documents
incorporated by reference therein, being collectively referred to herein as the “SEC Reports”). As of their
respective dates, the SEC Reports complied in all material respects with the requirements of the Securities Act and the Exchange
Act and the rules and regulations of the Commission promulgated thereunder, and none of the SEC Reports, when filed, contained
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order
to make the statements therein, in the light of the circumstances under which they were made, not misleading. The financial statements
of the Company included in the SEC Reports comply in all material respects with applicable accounting requirements and the rules
and regulations of the Commission with respect thereto as in effect at the time of filing. Such financial statements have been
prepared in accordance with United States generally accepted accounting principles applied on a consistent basis during the periods
involved (“GAAP”), except as may be otherwise specified in such financial statements or the notes thereto and
except that unaudited financial statements may not contain all footnotes required by GAAP, and fairly present in all material
respects the financial position of the Company and the Group Entities as of and for the dates thereof and the results of operations
and cash flows for the periods then ended, subject, in the case of unaudited statements, to normal, immaterial, year-end audit
adjustments. The financial statements, including the notes thereto and supporting schedules included in the Registration Statement,
the Disclosure Package and the Prospectus, fairly present in all material respects the financial position and the results of operations
of the Company at the dates and for the periods to which they apply; and such financial statements have been prepared in conformity
with GAAP, consistently applied throughout the periods involved (provided that unaudited interim financial statements are subject
to year-end audit adjustments that are not expected to be material in the aggregate and do not contain all footnotes required
by GAAP); and the supporting schedules included in the Registration Statement present fairly in all material respects the information
required to be stated therein. Except as included therein, no historical or pro forma financial statements are required to be
included in the Registration Statement, the Disclosure Package or the Prospectus under the Securities Act or the Securities Act
Regulations. The pro forma and pro forma as adjusted financial information and the related notes, if any, included in the Registration
Statement, the Disclosure Package and the Prospectus have been properly compiled and prepared in accordance with the applicable
requirements of the Securities Act and the Securities Act Regulations and present fairly in all material respects the information
shown therein, and the assumptions used in the preparation thereof are reasonable and the adjustments used therein are appropriate
to give effect to the transactions and circumstances referred to therein. All disclosures contained in the Registration Statement,
the Disclosure Package or the Prospectus regarding “non-GAAP financial measures” (as such term is defined by the rules
and regulations of the Commission), if any, comply with Regulation G of the Exchange Act and Item 10 of Regulation S-K of the
Securities Act, to the extent applicable. Each of the Registration Statement, the Disclosure Package and the Prospectus discloses
all material off-balance sheet transactions, arrangements, obligations (including contingent obligations), and other relationships
of the Company with unconsolidated entities or other persons that may have a material current or future effect on the Company’s
financial condition, changes in financial condition, results of operations, liquidity, capital expenditures, capital resources,
or significant components of revenues or expenses. Except as disclosed in the Registration Statement, the Disclosure Package and
the Prospectus, (a) the Company has not incurred any material liabilities or obligations, direct or contingent, or entered into
any material transactions other than in the ordinary course of business, (b) the Company has not declared or paid any dividends
or made any distribution of any kind with respect to its capital stock, (c) there has not been any change in the capital stock
of the Company (other than (i) grants under any stock compensation plan and (ii) shares of common stock issued upon exercise or
conversion of option, warrants or convertible securities described in the Registration Statement, the Disclosure Package and the
Prospectus), and (d) there has not been any Material Adverse Change in the Company’s long-term or short-term debt.

 

    	 

     

    

 

7.8
Authorized Capital; Options, etc. The Company had, at the date or dates indicated in the Registration Statement, the Disclosure
Package and the Prospectus, the duly authorized, issued and outstanding capitalization as set forth therein. Based on the assumptions
stated in the Registration Statement, the Disclosure Package and the Prospectus, the Company will have on the Closing Date the
adjusted stock capitalization set forth therein. Except as set forth in, or contemplated by, the Registration Statement, the Disclosure
Package and the Prospectus, on the Effective Date, as of the Initial Sale Time, on the Closing Date, there will be no stock options,
warrants, or other rights to purchase or otherwise acquire any authorized, but unissued shares of Common Stock of the Company
or any security convertible or exercisable into shares of Common Stock of the Company, or any contracts or commitments to issue
or sell shares of Common Stock or any such options, warrants, rights or convertible securities.

 

7.9
Valid Issuance of Securities, etc.

 

7.9.1
Outstanding Securities. All issued and outstanding securities of the Company issued prior to the transactions contemplated
by this Agreement have been duly authorized and validly issued and are fully paid and non-assessable; the holders thereof have
no rights of rescission with respect thereto, and are not subject to personal liability by reason of being such holders; and none
of such securities were issued in violation of the preemptive rights of any holders of any security of the Company or similar
contractual rights granted by the Company. The authorized shares of Common Stock and other outstanding securities conform in all
material respects to all statements relating thereto contained in the Registration Statement, the Disclosure Package and the Prospectus.
The offers and sales of the outstanding shares of Common Stock were at all relevant times either registered under the Securities
Act and the applicable foreign or state securities or “blue sky” laws or, based in part on the representations and
warranties of the purchasers of such shares, exempt from such registration requirements.

 

7.9.2
Securities Sold Pursuant to this Agreement. The Securities and Placement Agent Securities have been duly authorized for
issuance and sale and, when issued and paid for, will be validly issued, fully paid and non-assessable; the holders thereof are
not and will not be subject to personal liability by reason of being such holders; the Securities and Placement Agent Securities
are not and will not be subject to the preemptive rights of any holders of any security of the Company or similar contractual
rights granted by the Company; and all corporate action required to be taken for the authorization, issuance and sale of the Securities
and Placement Agent Securities has been duly and validly taken. The Common Stock underlying the Placement Agent Warrants have
been duly authorized and reserved for issuance by all necessary corporate action on the part of the Company and when paid for,
if applicable, and issued in accordance with the Placement Agent Warrants, such Common Stock will be validly issued, fully paid
and non-assessable; and the holders thereof are not and will not be subject to personal liability by reason of being such holders.
The Securities conform in all material respects to all statements with respect thereto contained in the Registration Statement,
the Disclosure Package and the Prospectus.

 

7.10
Registration Rights of Third Parties. Except as set forth in the Registration Statement, the Disclosure Package and the
Prospectus, no holders of any securities of the Company or any rights exercisable for or convertible or exchangeable into securities
of the Company have the right to require the Company to register any such securities of the Company under the Securities Act or
to include any such securities in a registration statement to be filed by the Company.

 

    	 

     

    

 

7.11
Validity and Binding Effect of Agreements. This Agreement and the Placement Agent Warrant each has been duly and validly
authorized by the Company, and, when executed and delivered, will constitute, the valid and binding agreement of the Company,
enforceable against the Company in accordance with its respective terms, except: (i) as such enforceability may be limited by
bankruptcy, insolvency, reorganization or similar laws affecting creditors’ rights generally; (ii) as enforceability of
any indemnification or contribution provision may be limited under the federal and state securities laws; and (iii) that the remedy
of specific performance and injunctive and other forms of equitable relief may be subject to the equitable defenses and to the
discretion of the court before which any proceeding therefor may be brought.

 

7.12
No Conflicts, etc. The execution, delivery and performance by the Company of this Agreement and the Placement Agent Warrants
and all ancillary documents, the consummation by the Company of the transactions herein and therein contemplated and the compliance
by the Company with the terms hereof and thereof do not and will not, with or without the giving of notice or the lapse of time
or both: (i) result in a material breach of, or conflict with any of the terms and provisions of, or constitute a material default
under, or result in the creation, modification, termination or imposition of any lien, charge or encumbrance upon any property
or assets of the Company pursuant to the terms of any agreement or instrument to which the Company is a party; (ii) result in
any violation of the provisions of the Company’s Certificate of Incorporation (as the same may be amended or restated from
time to time, the “Charter”) or the by-laws of the Company (as the same may be amended or restated from time
to time, the “Bylaws”); or (iii) violate any existing applicable law, rule, regulation, judgment, order or
decree of any Governmental Entity as of the date hereof.

 

7.13
Regulatory. Except as described in the Registration Statement, the Disclosure Package and the Prospectus or as would not
reasonably be expected to result, individually or in the aggregate, in a Material Adverse Change: (i) the Company is and has been
in material compliance with statutes, laws, ordinances, rules and regulations applicable to the Company (collectively, “Applicable
Laws”); (ii) the Company possesses all licenses, certificates, approvals, clearances, consents, authorizations, qualifications,
registrations, permits, and supplements or amendments thereto required by any such Applicable Laws and/or to carry on its businesses
as now conducted (“Authorizations”) and such Authorizations are valid and in full force and effect and the
Company is not in violation of any term of any such Authorizations; (iii) the Company has not received notice of any claim, action,
suit, proceeding, hearing, enforcement, investigation, arbitration or other action from any Governmental Entity or third party
alleging that any product, operation or activity is in violation of any Applicable Laws or Authorizations or has any knowledge
that any such Governmental Entity or third party is considering any such claim, litigation, arbitration, action, suit, investigation
or proceeding, nor, to the best of the Company’s knowledge, has there been any material noncompliance with or violation
of any Applicable Laws by the Company that could reasonably be expected to require the issuance of any such communication or result
in an investigation, corrective action, or enforcement action by any Governmental Entity; and (iv) the Company has not received
notice that any Governmental Entity has taken, is taking or intends to take action to limit, suspend, modify or revoke any Authorizations
or has any knowledge that any such Governmental Entity has threatened or is considering such action. Neither the Company nor,
to the Company’s knowledge, any of its directors, officers, employees or agent has been convicted of any crime under any
Applicable Laws.

 

7.14
No Defaults; Violations. No material default exists in the due performance and observance of any term, covenant or condition
of any material license, contract, indenture, mortgage, deed of trust, note, loan or credit agreement, or any other agreement
or instrument evidencing an obligation for borrowed money, or any other material agreement or instrument to which the Company
is a party or by which the Company may be bound or to which any of the properties or assets of the Company is subject. The Company
is not (i) in violation of any term or provision of its Charter or Bylaws, or (ii) in violation of any franchise, license, permit,
applicable law, rule, regulation, judgment or decree of any Governmental Entity applicable to the Company.

 

7.15
Corporate Power; Licenses; Consents.

 

7.15.1
Except as described in the Registration Statement, the Disclosure Package and the Prospectus, the Company has all requisite corporate
power and authority, and has all necessary authorizations, approvals, orders, licenses, certificates and permits of and from all
governmental regulatory officials and bodies that it needs as of the date hereof to conduct its business purpose as described
in the Registration Statement, the Disclosure Package and the Prospectus.

 

    	 

     

    

 

7.15.2
The Company has all corporate power and authority to enter into this Agreement and to carry out the provisions and conditions
hereof, and all consents, authorizations, approvals and orders required in connection therewith have been obtained. No consent,
authorization or order of, and no filing with, any court, government agency or other body is required for the valid issuance,
sale and delivery of the Securities and Placement Agent Securities and the consummation of the transactions and agreements contemplated
by this Agreement and as contemplated by the Registration Statement, the Disclosure Package and the Prospectus, except with respect
to applicable federal and state securities laws and the rules and regulations of the Financial Industry Regulatory Authority,
Inc. (“FINRA”).

 

7.16
Litigation; Governmental Proceedings. There is no material action, suit, proceeding, inquiry, arbitration, investigation,
litigation or governmental proceeding pending or, to the Company’s knowledge, threatened against, or involving the Company
or, to the Company’s knowledge, any executive officer or director which has not been disclosed in the Registration Statement,
the Disclosure Package and the Prospectus or in connection with the Company’s listing application for the Shares on the
Exchange.

 

7.17
Good Standing. The Company has been duly organized and is validly existing as a corporation and is in good standing under
the laws of the State of Nevada as of the date hereof, and is duly qualified to do business and is in good standing in each other
jurisdiction in which its ownership or lease of property or the conduct of business requires such qualification, except where
the failure to qualify, singularly or in the aggregate, would not have or reasonably be expected to result in a Material Adverse
Change.

 

7.18
Insurance. The Company carries or is entitled to the benefits of insurance solely with respect to office contents, business
interruption, money protection, personal accident, public liability and employees’ compensation, with, to the Company’s
knowledge, reputable insurers, and in such amounts and covering such risks which the Company believes are reasonably adequate,
and all such insurance is in full force and effect. The Company has no reason to believe that it will not be able (i) to renew
its existing insurance coverage as and when such policies expire or (ii) to obtain comparable coverage from similar institutions
as may be necessary or appropriate to conduct its business as now conducted and at a cost that would not result in a Material
Adverse Change.

 

7.19
Transactions Affecting Disclosure to FINRA.

 

7.19.1
Finder’s Fees. Except as described in the Registration Statement, the Disclosure Package and the Prospectus, there
are no claims, payments, arrangements, agreements or understandings relating to the payment of a finder’s, consulting or
origination fee by the Company or any executive officer or director of the Company (each an “Insider”) with
respect to the sale of the Securities hereunder or any other arrangements, agreements or understandings of the Company or, to
the Company’s knowledge, any of its stockholders that may affect the Placement Agent’ compensation, as determined
by FINRA.

 

7.19.2
Payments Within Twelve (12) Months. Except as described in the Registration Statement, the Disclosure Package and the Prospectus,
the Company has not made any direct or indirect payments (in cash, securities or otherwise) to: (i) any person, as a finder’s
fee, consulting fee or otherwise, in consideration of such person raising capital for the Company or introducing to the Company
persons who raised or provided capital to the Company; (ii) any FINRA member; or (iii) any person or entity that has any direct
or indirect affiliation or association with any FINRA member, within the twelve (12) months prior to the date hereof, other than
the payment to the Placement Agent as provided hereunder in connection with the Offering.

 

7.19.3
Use of Proceeds. None of the net proceeds of the Offering will be paid by the Company to any participating FINRA member
or its affiliates, except as specifically authorized herein.

 

7.19.4
FINRA Affiliation. There is no (i) officer or director of the Company, (ii) beneficial owner of 5% or more of any class
of the Company’s securities or (iii) beneficial owner of the Company’s unregistered equity securities which were acquired
during the 180-day period immediately preceding the original filing of the Registration Statement, that (a) is an affiliate or
associated person of a FINRA member participating in the Offering (as determined in accordance with the rules and regulations
of FINRA); (b) is required to register as a “broker” or “dealer” in accordance with the provisions of
the Exchange Act or the Exchange Act Regulations, or (c) has any direct or indirect affiliation or association with any member
firm of FINRA (as determined in accordance with the rules and regulations of FINRA).

 

    	 

     

    

 

7.19.5
Information. To the Company’s knowledge, all information provided by the Company’s officers and directors in
their FINRA Questionnaires to counsel to the Placement Agent specifically for use by counsel to the Placement Agent in connection
with its Public Offering System filings (and related disclosure) with FINRA is true, correct and complete in all material respects.

 

7.20
Foreign Corrupt Practice Act. Neither the Company nor, to the Company’s knowledge, any director, officer, agent,
employee or affiliate of the Company or any other person acting on behalf of the Company, has, directly or indirectly, given or
agreed to give any money, gift or similar benefit (other than legal price concessions to customers in the ordinary course of business)
to any customer, supplier, employee or agent of a customer or supplier, or official or employee of any Governmental Entity or
any political party or candidate for office (domestic or foreign) or other person who was, is, or may be in a position to help
or hinder the business of the Company (or assist it in connection with any actual or proposed transaction) that (i) might subject
the Company to any damage or penalty in any civil, criminal or governmental litigation or proceeding, (ii) if not given in the
past, might have had a Material Adverse Change or (iii) if not continued in the future, might adversely affect the assets, business,
operations or prospects of the Company. The Company has taken reasonable steps to ensure that its accounting controls and procedures
are sufficient to cause the Company to comply in all material respects with the Foreign Corrupt Practices Act of 1977, as amended.
The Company has not violated any provision of the anti-corruption laws in China, Hong Kong, Samoa, Malaysia or the British Virgin
Islands.

 

7.21
Compliance with OFAC. Neither of the Company nor, to the Company’s knowledge, any director, officer, agent, employee
or affiliate of the Company or any other person acting on behalf of the Company, is currently subject to any U.S. sanctions administered
by the Office of Foreign Assets Control of the U.S. Department of the Treasury (“OFAC”), and the Company will
not, directly or indirectly, use the proceeds of the Offering hereunder, or lend, contribute or otherwise make available such
proceeds to any subsidiary, joint venture partner or other person or entity, for the purpose of financing the activities of any
person currently subject to any U.S. sanctions administered by OFAC.

 

7.22
Money Laundering Laws. The operations of the Company are and have been conducted at all times in compliance with applicable
financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended,
the money laundering statutes of all applicable jurisdictions, the rules and regulations thereunder and any related or similar
rules, regulations or guidelines, issued, administered or enforced by any Governmental Entity (collectively, the “Money
Laundering Laws”); and no action, suit or proceeding by or before any Governmental Entity involving the Company with
respect to the Money Laundering Laws is pending or, to the knowledge of the Company, threatened.

 

7.23
Officers’ Certificate. Any certificate signed by any duly authorized officer of the Company and delivered to the
Placement Agent or to Placement Agent’ Counsel shall be deemed a representation and warranty by the Company to the Placement
Agent as to the matters covered thereby.

 

7.24
Related Party Transactions. There are no business relationships or related party transactions involving the Company or
any other person required to be described in the Registration Statement, the Disclosure Package and the Prospectus that have not
been described as required.

 

7.25
Board of Directors. The qualifications of the persons serving as board members and the overall composition of the board
comply with the Exchange Act, the Exchange Act Regulations, the Sarbanes-Oxley Act of 2002 and the rules promulgated thereunder
(the “Sarbanes-Oxley Act”) applicable to the Company and the listing rules of the Exchange. At least one member
of the Audit Committee of the Board of Directors of the Company qualifies as an “audit committee financial expert,”
as such term is defined under Regulation S-K and the listing rules of the Exchange. In addition, at least a majority of the persons
serving on the Board of Directors qualify as “independent,” as defined under the listing rules of the Exchange.

 

7.26
Sarbanes-Oxley Compliance. Except as disclosed in the Registration Statement, Disclosure Package and Prospectus:

 

    	 

     

    

 

7.26.1
The Company has developed and currently maintains disclosure controls and procedures that will comply with Rule 13a-15 or 15d-15
under the Exchange Act Regulations applicable to it, and such controls and procedures are effective to ensure that all material
information concerning the Company will be made known on a timely basis to the individuals responsible for the preparation of
the Company’s Exchange Act filings and other public disclosure documents.

 

7.26.2
The Company is, or at the Initial Sale Time and on the Closing Date will be, in material compliance with the provisions of the
Sarbanes-Oxley Act applicable to it, and has implemented or will implement such programs and taken reasonable steps to ensure
the Company’s future compliance (not later than the relevant statutory and regulatory deadlines therefor) with all of the
material provisions of the Sarbanes-Oxley Act.

 

7.27
Accounting Controls. The Company maintains a system of “internal control over financial reporting” (as defined
under Rules 13a-15 and 15d-15 under the Exchange Act Regulations) that comply with the requirements of the Exchange Act and have
been designed by, or under the supervision of, its principal executive and principal financial officers, or persons performing
similar functions, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial
statements for external purposes in accordance with GAAP, including, but not limited to, internal accounting controls sufficient
to provide reasonable assurance that (i) transactions are executed in accordance with management’s general or specific authorizations;
(ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with GAAP and to maintain
asset accountability; (iii) access to assets is permitted only in accordance with management’s general or specific authorization;
and (iv) the recorded accountability for assets is compared with the existing assets at reasonable intervals and appropriate action
is taken with respect to any differences. Except as disclosed in the Registration Statement, the Disclosure Package and the Prospectus,
the Company is not aware of any material weaknesses in its internal controls. The Auditors (during the time of their engagement)
and the Audit Committee of the Board of Directors of the Company have been advised of: (i) all significant deficiencies and material
weaknesses, if any, in the design or operation of internal controls over financial reporting which are known to the Company’s
management and that have adversely affected or are reasonably likely to adversely affect the Company’ ability to record,
process, summarize and report financial information; and (ii) any fraud, if any, known to the Company’s management, whether
or not material, that involves management or other employees who have a significant role in the Company’s internal controls
over financial reporting.

 

7.28
No Investment Company Status. The Company is not and, after giving effect to the Offering and the application of the proceeds
thereof as described in the Registration Statement, the Disclosure Package and the Prospectus, will not be, required to register
as an “investment company,” as defined in the Investment Company Act of 1940, as amended.

 

7.29
No Labor Disputes. No material labor dispute with the employees of the Company exists or, to the knowledge of the Company,
is imminent.

 

7.30
Intellectual Property Rights. To the Company’s knowledge, the Company has, or can acquire on reasonable terms, ownership
of and/or license to, or otherwise has the right to use, all inventions, know-how (including trade secrets and other unpatented
and/or unpatentable proprietary or confidential information, systems or procedures), patents and patent rights trademarks, service
marks and trade names, copyrights, (collectively “Intellectual Property”) material to carrying on its business
as described in the Prospectus. The Company has not received any correspondence relating to (A) infringement or misappropriation
of, or conflict with, any Intellectual Property of a third party; (B) asserted rights of others with respect to any Intellectual
Property of the Company; or (C) assertions that any Intellectual Property of the Company is invalid or otherwise inadequate to
protect the interest of the Company, that in each case (if the subject of any unfavorable decision, ruling or finding), individually
or in the aggregate, would have or would reasonably be expected to result in a Material Adverse Change. There are no third parties
who have been able to establish any material rights to any Intellectual Property, except for the retained rights of the owners
or licensors of any Intellectual Property that is licensed to the Company. There is no pending or, to the Company’s knowledge,
threatened action, suit, proceeding or claim by others: (A) challenging the validity, enforceability or scope of any Intellectual
Property of the Company or (B) challenging the Company’s rights in or to any Intellectual Property or (C) that the Company
materially infringes, misappropriates or otherwise violates or conflicts with any Intellectual Property or other proprietary rights
of others. The Company has complied in all material respects with the terms of each agreement described in the Registration Statement,
Disclosure Package or Prospectus pursuant to which any Intellectual Property is licensed to the Company, and all such agreements
related to products currently made or sold by the Company, or to product candidates currently under development, are in full force
and effect. All patents issued in the name of, or assigned to, the Company, and all patent applications made by or on behalf of
the Company (collectively, the “Company Patents”) have been duly and properly filed. To the Company’s
knowledge, the Company is the sole owner of the Company Patents.

 

    	 

     

    

 

7.31
Taxes. The Company has filed all returns (as hereinafter defined) required to be filed with taxing authorities prior to
the date hereof or has duly obtained extensions of time for the filing thereof. The Company has paid all taxes (as hereinafter
defined) shown as due on such returns that were filed and has paid all taxes imposed on or assessed against the Company, except
for such exceptions as could not be expected, individually or in the aggregate, to have a Material Adverse Change. The provisions
for taxes payable, if any, shown on the financial statements filed with or as part of the Registration Statement are sufficient
for all accrued and unpaid taxes, whether or not disputed, and for all periods to and including the dates of such consolidated
financial statements. Except as disclosed in writing to the Placement Agent, (i) no issues have been raised (and are currently
pending) by any taxing authority in connection with any of the returns or taxes asserted as due from the Company, and (ii) no
waivers of statutes of limitation with respect to the returns or collection of taxes have been given by or requested from the
Company. The term “taxes” mean all federal, state, local, foreign and other net income, gross income, gross receipts,
sales, use, ad valorem, transfer, franchise, profits, license, lease, service, service use, withholding, payroll, employment,
excise, severance, stamp, occupation, premium, property, windfall profits, customs, duties or other taxes, fees, assessments or
charges of any kind whatever, together with any interest and any penalties, additions to tax or additional amounts with respect
thereto. The term “returns” means all returns, declarations, reports, statements and other documents required to be
filed in respect to taxes.

 

7.32
Compliance with Laws. The Company: (A) is and at all times has been in compliance with all Applicable Laws, except as would
not, individually or in the aggregate, reasonably be expected to result in a Material Adverse Change; (B) has not received any
correspondence from any Governmental Entity alleging or asserting noncompliance with any Applicable Laws or any Authorizations;
(C) possesses all material Authorizations and such Authorizations are valid and in full force and effect and the Company is not
in material violation of any term of any such Authorizations, in each case except as would not, individually or in the aggregate,
reasonably be expected to have a Material Adverse Change; (D) has not received written notice of any claim, action, suit, proceeding,
hearing, enforcement, investigation, arbitration or other action from any Governmental Entity or third party alleging that any
product operation or activity is in violation of any Applicable Laws or Authorizations and has no knowledge that any such Governmental
Entity or third party is considering any such claim, litigation, arbitration, action, suit, investigation or proceeding; (E) has
not received written notice that any Governmental Entity has taken, is taking or intends to take action to limit, suspend, modify
or revoke any Authorizations; and (F) has filed, obtained, maintained or submitted all material reports, documents, forms, notices,
applications, records, claims, submissions and supplements or amendments as required by any Applicable Laws or Authorizations
and that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments
were complete and correct in all material respects on the date filed (or were corrected or supplemented by a subsequent submission).

 

7.33
[Intentionally Omitted]

 

7.34
Industry Data. The statistical and market-related data included in each of the Registration Statement, the Disclosure Package
and the Prospectus are based on or derived from sources that the Company reasonably and in good faith believes are reliable and
accurate or represent the Company’s good faith estimates that are made on the basis of data derived from such sources.

 

7.35
Forward-Looking Statements. No forward-looking statement (within the meaning of Section 27A of the Securities Act and Section
21E of the Exchange Act) is contained in the Registration Statement, the Disclosure Package or the Prospectus has been made or
reaffirmed without a reasonable basis or has been disclosed other than in good faith.

 

7.36
Margin Securities. The Company owns no “margin securities” as that term is defined in Regulation U of the Board
of Governors of the Federal Reserve System (the “Federal Reserve Board”), and none of the proceeds of Offering
will be used, directly or indirectly, for the purpose of purchasing or carrying any margin security, for the purpose of reducing
or retiring any indebtedness which was originally incurred to purchase or carry any margin security or for any other purpose which
might cause any of the shares of Common Stock to be considered a “purpose credit” within the meanings of Regulation
T, U or X of the Federal Reserve Board.

 

    	 

     

    

 

7.37
Integration. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf has, directly
or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that
would cause the Offering to be integrated with prior offerings by the Company for purposes of the Securities Act that would require
the registration of any such securities under the Securities Act.

 

7.38
Confidentiality and Non-Competition. To the Company’s knowledge, no director, officer, key employee or consultant
of the Company is subject to any confidentiality, non-disclosure, non-competition agreement or non-solicitation agreement with
any employer or prior employer, other than the Company, that could reasonably be expected to materially affect his ability to
be and act in his respective capacity of the Company or be expected to result in a Material Adverse Change.

 

7.39
Dividends. Except to the extent described in the Registration Statement, the Disclosure Package and the Prospectus, all
dividends and other distributions declared and payable on the equity interests of the Company and its subsidiaries may under current
laws and regulations of BVI, Anguilla, Belize, Seychelles, the PRC, Hong Kong, or Malaysia be converted into foreign currency
that may be freely transferred out of BVI, Anguilla, Belize, Seychelles, the PRC, Hong Kong, or Malaysia, as the case may be,
and all such dividends and other distributions will not be subject to withholding or other taxes under the laws and regulations
of such jurisdictions and are otherwise free and clear of any other tax, withholding or deduction in such jurisdictions without
the necessity of obtaining any governmental authorization.

 

7.40
No Commodity Contracts. The Company is not engaged in any trading activities involving commodity contracts or other trading
contracts which are not currently traded on a securities or commodities exchange and for which the market value cannot be determined.

 

7.41
Compliance with PRC Overseas Investment and Listing Regulations. Except as described in the Registration Statement, the
Disclosure Package and the Prospectus, each of the Company and the Group Entities that was incorporated outside of the PRC has
complied with, and has taken commercially reasonable steps to comply with and to ensure compliance by each of its shareholders,
option holders, directors, officers and employees that is, or is directly or indirectly owned or controlled by, a PRC resident
or citizen with any applicable rules and regulations of the relevant PRC government agencies (including but not limited to the
Ministry of Commerce, the National Development and Reform Commission and the State Administration of Foreign Exchange) relating
to overseas investment by PRC residents and citizens (the “PRC Overseas Investment and Listing Regulations”),
including, without limitation, requesting each shareholder, option holder, director, officer and employee that is, or is directly
or indirectly owned or controlled by, a PRC resident or citizen to complete any registration and other procedures required under
the PRC Overseas Investment and Listing Regulations.

 

7.42
Compliance with PRC Mergers and Acquisitions Rules. The Company is aware of and has been advised as to the content of the
Rules on Mergers and Acquisitions of Domestic Enterprises by Foreign Investors (the “PRC Mergers and Acquisition Rules”)
jointly promulgated by the Ministry of Commerce, the State Assets Supervision and Administration Commission, the State Tax Administration,
the State Administration of Industry and Commerce, the China Securities Regulatory Commission (the “CSRC”)
and the State Administration of Foreign Exchange of the PRC on August 8, 2006 and effective as of September 8, 2006, including
the relevant provisions thereof which purport to require offshore special purpose entities formed for listing purposes and controlled
directly or indirectly by PRC companies or individuals, to obtain the approval of the CSRC prior to the listing and trading of
their securities on an overseas stock exchange. The Company has received legal advice specifically with respect to the PRC Mergers
and Acquisitions Rules from its PRC counsel and the Company understands such legal advice. The issuance and sale of the Securities,
the listing and trading of the Securities on the Exchange and the consummation of the transactions contemplated by this Agreement
are not and will not be, as of the date hereof or on the Closing Date, as the case may be, materially and adversely affected by
the PRC Mergers and Acquisitions Rules or any official clarifications, guidance, interpretations or implementation rules in connection
with or related to the PRC Mergers and Acquisitions Rules (collectively, the “PRC Mergers and Acquisitions Rules and
Related Clarifications”).

 

    	 

     

    

 

7.43
Compliance with PRC Anti-Monopoly Law and Regulations. The Company is aware of and has been advised as to the content of
the PRC Anti-monopoly Law, which became effective on August 1, 2008, and the related rules, regulations and guidelines issued
by various PRC governmental authorities (the “PRC Anti-Monopoly Law and Regulations”). Except as described
in the Registration Statement, the Disclosure Package and the Prospectus, all acquisitions and other transactions conducted by
the Company or any Group Entity have complied with the PRC Anti-Monopoly Law and Regulations.

 

7.44
Lock-Up Period

 

7.44.1
Each officer and director (each an “Insider”) and each beneficial owner of 10% or more of the Company holding
outstanding Shares (or securities convertible into Shares) (together with the Insiders, the “Lock-Up Parties”)
have agreed pursuant to executed Lock-Up Agreements in the form attached hereto as Exhibit C that for a period ending 180
days after the Closing Date (the “Lock-Up Period”), such persons and their affiliated parties shall not offer,
pledge, sell, contract to sell, grant, lend or otherwise transfer or dispose of, directly or indirectly, any capital stock of
the Company, including Shares, or any securities convertible into or exercisable or exchangeable for such capital stock, without
the consent of the Placement Agent, with certain exceptions. The Placement Agent may consent to an early release from the applicable
Lock-Up period if, in its opinion, the market for the capital stocks would not be adversely impacted by sales and in cases of
financial emergency of an Insider or other stockholder.

 

7.44.2
The Company, on behalf of itself and any successor entity, has agreed that, without the prior written consent of the Placement
Agent, it will not, for a period ending 180 days after the Closing Date, (i) offer, pledge, sell, contract to sell, sell any option
or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, lend, or otherwise
transfer or dispose of, directly or indirectly, any shares of capital stock of the Company or any securities convertible into
or exercisable or exchangeable for shares of capital stock of the Company; (ii) file or cause to be filed any registration statement
with the Commission relating to the offering of any shares of capital stock of the Company or any securities convertible into
or exercisable or exchangeable for shares of capital stock of the Company or (iii) enter into any swap or other arrangement that
transfers to another, in whole or in part, any of the economic consequences of ownership of capital stock of the Company, whether
any such transaction described in clause (i), (ii) or (iii) above is to be settled by delivery of shares of capital stock of the
Company or such other securities, in cash or otherwise. The restrictions contained in this paragraph 7.44.2 shall not apply to
(i) the issuance by the Company of Shares upon the exercise of an option or warrant or the conversion of a security outstanding
on the date hereof of, provided that the Placement Agent has been advised in writing of such issuance prior to the date hereof
or (ii) the issuance by the Company of options to purchase or shares of capital stock or restricted stock of the Company under
any stock compensation plan of the Company outstanding on the date hereof. For purposes of subclause (i) in this paragraph, the
Placement Agent acknowledges that disclosure in the Registration Statement filed prior to the date hereof of any outstanding option
or warrant shall be deemed to constitute prior written notice to the Placement Agent.

 

7.44.3
Notwithstanding the foregoing, if (i) the Company issues an earnings release or material news, or a material event relating to
the Company occurs, during the last 17 days of the Lock-Up Period, or (ii) prior to the expiration of the Lock-Up Period, the
Company announces that it will release earnings results during the 16-day period beginning on the last day of the Lock-Up Period,
the restrictions imposed by paragraph 7.45 shall continue to apply until the expiration of the 18-day period beginning on the
issuance of the earnings release or the occurrence of the material news or material event, unless the Placement Agent waives such
extension.

 

7.45
Issuance of Additional Shares. The Company agrees that it will not issue additional shares of preferred stock or any underlying
Shares during the offering period. It further agrees that it will not issue additional shares for a period ending 180 days after
the Closing Date without the Placement Agent’s written consent.

 

8.
Conditions of the Obligations of the Placement Agent.

 

The
obligations of the Placement Agent hereunder shall be subject to the accuracy of the representations and warranties, in all material
respects, on the part of the Company set forth in Section 7 hereof, in each case as of the date hereof and as of the Closing Date
as though then made, to the timely performance by each of the Company of its covenants and other obligations hereunder on and
as of such dates, and to each of the following additional conditions:

 

    	 

     

    

 

8.1
Regulatory Matters.

 

8.1.1
Effectiveness of Registration Statement; Rule 424 Information. The Registration Statement is effective on the date of this
Agreement, and, on the Closing Date no stop order suspending the effectiveness of the Registration Statement or any post-effective
amendment thereto has been issued under the Securities Act, no order preventing or suspending the use of any Preliminary Prospectus
or the Prospectus has been issued and no proceedings for any of those purposes have been instituted or are pending or, to the
Company’s knowledge, contemplated by the Commission. The Company has complied with each request (if any) from the Commission
for additional information. All filings with the Commission required by Rule 424 under the Securities Act to have been filed by
the Closing Date shall have been made within the applicable time period prescribed for such filing by Rule 424.

 

8.1.2
FINRA Clearance. On or before the Closing Date of this Agreement, the Placement Agent shall have received clearance from
FINRA as to the amount of compensation allowable or payable to the Placement Agent as described in the Registration Statement.

 

8.2
Company Counsel Matters.

 

8.2.1
Opinion of U.S. Counsel. On the Closing Date, the Placement Agent shall have received the favorable opinion of Loeb &
Loeb, LLP, U.S. counsel for the Company, dated the Closing Date and addressed to the Placement Agent, substantially in form and
substance reasonably satisfactory to the Placement Agent.

 

8.2.2
Opinion of PRC Counsel. On the Closing Date, the Placement Agent shall have received the favorable opinion of Guangdong
Shenxin Lawyers (also known as广东深信律师事务所) , PRC counsel for the
Company, dated the Closing Date and addressed to the Placement Agent, substantially in form and substance reasonably satisfactory
to the Placement Agent.

 

8.2.3
Opinion of Hong Kong Counsel. On the Closing Date, the Placement Agent shall have received the favorable opinion of Khoo
& Co, Hong Kong counsel for the Company, dated the Closing Date and addressed to the Placement Agent, substantially in form
and substance reasonably satisfactory to the Placement Agent.

 

8.2.4
Opinion of Malaysia Counsel. On the Closing Date, the Placement Agent shall have received the favorable opinion of N S
Leong & S T Low Law Firm, Malaysia counsel for the Company, dated the Closing Date and addressed to the Placement Agent, substantially
in form and substance reasonably satisfactory to the Placement Agent.

 

8.3
Comfort Letters.

 

8.3.1
Comfort Letter. At the time this Agreement is executed, Placement Agent shall have received from each of the Auditors a
cold comfort letter containing statements and information of the type customarily included in accountants’ comfort letters
with respect to the financial statements and certain financial information contained in the Registration Statement, the Disclosure
Package and the Prospectus, addressed to the Placement Agent and in form and substance satisfactory in all respects to Placement
Agent and to the Auditors, dated as of the date of this Agreement.

 

8.3.2
Bring-down Comfort Letter and CFO Certificate. At the Closing Date, the Placement Agent shall have received (i) from each
of the Auditors a letter, dated as of the Closing Date, to the effect that such Auditor reaffirms the statements made in the letter
furnished pursuant to Section 8.3.1. except that the specified date referred to shall be a date not more than three (3) business
days prior to the Closing Date; and (ii) from the Company a certificate of the chief financial officer of the Company, dated as
of the Closing Date, in a form and substance satisfactory to the Placement Agent.

 

    	 

     

    

 

8.4
Officers’ Certificates.

 

8.4.1
Officers’ Certificate. The Company shall have furnished to the Placement Agent a certificate, dated the Closing Date,
of its Chief Executive Officer and its Chief Financial Officer stating that (i) such officers have carefully examined the Registration
Statement, the Disclosure Package, any Issuer Free Writing Prospectus and the Prospectus and, in their opinion, the Registration
Statement and each amendment thereto, as of the Initial Sale Time and through the Closing Date did not include any untrue statement
of a material fact and did not omit to state a material fact required to be stated therein or necessary to make the statements
therein not misleading, and the Disclosure Package, as of the Initial Sale Time through the Closing Date, any Issuer Free Writing
Prospectus as of its date and as of the Closing Date, the Prospectus and each amendment or supplement thereto, as of the respective
date thereof and as of the Closing Date, did not include any untrue statement of a material fact and did not omit to state a material
fact necessary in order to make the statements therein, in the light of the circumstances in which they were made, not misleading,
(ii) since the filing of the most recent Registration Statement, no event has occurred which should have been set forth in a supplement
or amendment to the Registration Statement, the Disclosure Package or the Prospectus, (iii) to their knowledge after reasonable
investigation, as of the Closing Date, the representations and warranties of the Company in this Agreement are true and correct,
in all material respects, and the Company has complied, in all material respects, with all agreements and satisfied all conditions
on its part to be performed or satisfied hereunder at or prior to the Closing Date, and (iv) there has not been, subsequent to
the date of the most recent audited financial statements included in the Disclosure Package, any Material Adverse Change in the
financial position or results of operations of the Company, or any change or development that, singularly or in the aggregate,
would involve a Material Adverse Change or a prospective Material Adverse Change, in or affecting the condition (financial or
otherwise), results of operations, business, assets or prospects of the Company, except as set forth in the Prospectus.

 

8.4.2
Secretary’s Certificate. At of the Closing Date the Placement Agent shall have received a certificate of the Company
signed by the Secretary of the Company, dated the Closing Date, certifying: (i) that each of the Company’s Charter and Bylaws
attached to such certificate is true and complete, has not been modified and is in full force and effect; (ii) that each of the
Group Entities charter documents attached to such certificate is true and complete, has not been modified and is in full force
and effect; (iii) that the resolutions of the Company’s Board of Directors relating to the Offering attached to such certificate
are in full force and effect and have not been modified; and (iv) the good standing of the Company and each of the Group Entities.
The documents referred to in such certificate shall be attached to such certificate.

 

8.5
No Material Changes. Prior to and on the Closing Date: (i) there shall have been no Material Adverse Change or development
involving a prospective Material Adverse Change in the condition or prospects or the business activities, financial or otherwise,
of the Company from the latest dates as of which such condition is set forth in the Registration Statement, the Disclosure Package
and the Prospectus; (ii) no action, suit or proceeding, at law or in equity, shall have been pending or threatened against the
Company or any affiliates of the Company before or by any court or federal or state commission, board or other administrative
agency wherein an unfavorable decision, ruling or finding may materially adversely affect the business, operations, prospects
or financial condition or income of the Company, except as set forth in the Registration Statement, the Disclosure Package and
the Prospectus; (iii) no stop order shall have been issued under the Securities Act and no proceedings therefor shall have been
initiated or threatened by the Commission; and (iv) the Registration Statement, the Disclosure Package and the Prospectus and
any amendments or supplements thereto shall contain all material statements which are required to be stated therein in accordance
with the Securities Act and the Securities Act Regulations and shall conform in all material respects to the requirements of the
Securities Act and the Securities Act Regulations, and neither the Registration Statement, the Disclosure Package nor the Prospectus
nor any amendment or supplement thereto shall contain any untrue statement of a material fact or omit to state any material fact
required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were
made, not misleading.

 

8.6
[Intentionally Omitted].

 

8.7
Financial Public Relations Firm. As of the Closing Date, the Company shall have retained a financial public relations firm
reasonably acceptable to the Placement Agent and the Company, and shall retain such firm or another firm reasonably acceptable
to the Placement Agent for a period of not less than two (2) years after the Closing Date.

 

8.8
Reservation of Common Stock. So long the Placement Agent Warrants remain outstanding, the Company shall take all action
necessary to at all times have authorized, and reserved for the purpose of issuance, no less than 100% of the maximum number of
Common Stock underlying such Placement Agent Warrants.

 

    	 

     

    

 

8.9
Minimum Amount. There shall be subscription amounts for the purchase of the Securities equal to at least the Minimum Amount.

 

8.10
Additional Documents. At the Closing Date, Placement Agent Counsel shall have been furnished with such documents and opinions
as they may require in order to evidence the accuracy of any of the representations or warranties, or the fulfillment of any of
the conditions, herein contained; and all proceedings taken by the Company in connection with the issuance and sale of the Securities
as herein contemplated shall be satisfactory in form and substance to the Placement Agent and Placement Agent Counsel.

 

9
Indemnification and Contribution; Procedures.

 

9.1
Indemnification of Placement Agent. The Company agrees to indemnify and hold harmless the Placement Agent, their respective
affiliates and each person controlling such Placement Agent (within the meaning of Section 15 of the Securities Act), and the
directors, officers, agent and employees of such Placement Agent, their respective affiliates and each such controlling person
(each Placement Agent, and each such entity or person hereafter is referred to as an “Indemnified Person”)
from and against any losses, claims, damages, judgments, assessments, costs and other liabilities (collectively, the “Liabilities”),
and shall reimburse each Indemnified Person for all fees and expenses (including the reasonable fees and expenses of counsel for
the Indemnified Persons, except as otherwise expressly provided in this Agreement) (collectively, the “Expenses”)
and agrees to advance payment of such Expenses as they are incurred by an Indemnified Person in investigating, preparing, pursuing
or defending any actions, whether or not any Indemnified Person is a party thereto, arising out of or based upon any untrue statement
or alleged untrue statement of a material fact contained in (i) the Registration Statement, the Disclosure Package, the Preliminary
Prospectus, the Prospectus or in any Issuer Free Writing Prospectus (as from time to time each may be amended and supplemented);
(ii) any materials or information provided to investors by, or with the approval of, the Company in connection with the marketing
of the Offering, including any “road show” or investor presentations made to investors by the Company (whether in
person or electronically); or (iii) any application or other document or written communication (in this Section 9, collectively
called “application”) executed by the Company or based upon written information furnished by the Company in any jurisdiction
in order to qualify the Securities under the securities laws thereof or filed with the Commission, any state securities commission
or agency, any national securities exchange; or the omission or alleged omission therefrom of a material fact required to be stated
therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading,
unless such statement or omission was made in reliance upon, and in conformity with, the Placement Agent’ information. The
Company also agrees to reimburse each Indemnified Person for all Expenses as they are incurred in connection with such Indemnified
Person’s enforcement of his or its rights under this Agreement.

 

9.2
Procedure. Upon receipt by an Indemnified Person of actual notice of an action against such Indemnified Person with respect
to which indemnity may reasonably be expected to be sought under this Agreement, such Indemnified Person shall promptly notify
the Company in writing; provided that failure by any Indemnified Person so to notify the Company shall not relieve the Company
from any obligation or liability which the Company may have on account of this Section 9 or otherwise to such Indemnified Person,
except to the extent (and only to the extent) that its ability to assume the defense is actually impaired by such failure or delay.
The Company shall have the right to assume the defense of any such action (including the employment of counsel reasonably satisfactory
to the Placement Agent). Any Indemnified Person shall have the right to employ separate counsel in any such action and participate
in the defense thereof, but the fees and expenses of such counsel shall be at the expense of such Indemnified Person unless: (i)
the Company has failed promptly to assume the defense and employ counsel for the benefit of the Placement Agent and the other
Indemnified Persons or (ii) such Indemnified Person shall have been advised that in the opinion of counsel that there is an actual
or potential conflict of interest that prevents (or makes it imprudent for) the counsel engaged by the Company for the purpose
of representing the Indemnified Person, to represent both such Indemnified Person and any other person represented or proposed
to be represented by such counsel, it being understood, however, that the Company shall not be liable for the expenses of more
than one separate firm of attorneys for the Placement Agent and all Indemnified persons in any one action or series of related
actions in the same jurisdiction. The Company shall not be liable for any settlement of any action effected without its written
consent (which shall not be unreasonably withheld). In addition, the Company shall not, without the prior written consent of the
Placement Agent, settle, compromise or consent to the entry of any judgment in or otherwise seek to terminate any pending or threatened
action in respect of which advancement, reimbursement, indemnification or contribution may be sought hereunder (whether or not
such Indemnified Person is a party thereto) unless such settlement, compromise, consent or termination (i) includes an unconditional
release of each Indemnified Person, acceptable to such Indemnified Party, from all Liabilities arising out of such action for
which indemnification or contribution may be sought hereunder and (ii) does not include a statement as to or an admission of fault,
culpability or a failure to act, by or on behalf of any Indemnified Person. The advancement, reimbursement, indemnification and
contribution obligations of the Company required hereby shall be made by periodic payments of the amount thereof during the course
of the investigation or defense, as every Liability and Expense is incurred and is due and payable, and in such amounts as fully
satisfy each and every Liability and Expense as it is incurred (and in no event later than 30 days following the date of any invoice
therefore).

 

    	 

     

    

 

9.3
Indemnification of the Company. The Placement Agent agrees to indemnify and holds harmless the Company, its directors,
its officers who signed the Registration Statement and persons who control the Company within the meaning of Section 15 of the
Securities Act or Section 20 of the Exchange Act against any and all Liabilities, but only with respect to untrue statements or
omissions, or alleged untrue statements or omissions made in the Registration Statement, any Preliminary Prospectus, the Disclosure
Package or Prospectus or any amendment or supplement thereto, in reliance upon, and in strict conformity with, the Placement Agent’
Information. In case any action shall be brought against the Company or any other person so indemnified based on any Preliminary
Prospectus, the Registration Statement, the Disclosure Package or Prospectus or any amendment or supplement thereto, and in respect
of which indemnity may be sought against the Placement Agent, the Placement Agent shall have the rights and duties given to the
Company, and the Company and each other person so indemnified shall have the rights and duties given to the Placement Agent by
the provisions of Section 9.2. The Company agrees promptly to notify each of the Placement Agent of the commencement of any litigation
or proceedings against the Company or any of its officers, directors or any person, if any, who controls the Company within the
meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, in connection with the issuance and sale of the
Securities or in connection with the Registration Statement, the Disclosure Package, the Prospectus or any Issuer Free Writing
Prospectus; provided that failure by the Company so to notify the Placement Agent shall not relieve the Placement Agent from any
obligation or liability which the Placement Agent may have on account of this Section 9 or otherwise to the Company, except to
the extent (and only to the extent) that its ability to assume the defense is actually impaired by such failure or delay.

 

9.4
Contribution. In the event that a court of competent jurisdiction makes a finding that indemnity is unavailable to an Indemnified
Person, the Company shall contribute to the Liabilities and Expenses paid or payable by such Indemnified Person in such proportion
as is appropriate to reflect (i) the relative benefits to the Company, on the one hand, and to the Placement Agent and any other
Indemnified Person, on the other hand, of the matters contemplated by this Agreement or (ii) if the allocation provided by the
immediately preceding clause is not permitted by applicable law, not only such relative benefits but also the relative fault of
the Company, on the one hand, and the Placement Agent and any other Indemnified Person, on the other hand, in connection with
the matters as to which such Liabilities or Expenses relate, as well as any other relevant equitable considerations; provided
that in no event shall the Company contribute less than the amount necessary to ensure that all Indemnified Persons, in the aggregate,
are not liable for any Liabilities and Expenses in excess of the amount of commissions actually received by the Placement Agent
pursuant to this Agreement. The relative fault shall be determined by reference to, among other things, whether the untrue or
alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information
supplied by the Company on the one hand or the Placement Agent on the other and the parties’ relative intent, knowledge,
access to information and opportunity to correct or prevent such statement or omission. The Company and the Placement Agent agree
that it would not be just and equitable if contributions pursuant to this subsection (D) were determined by pro rata allocation
or by any other method of allocation which does not take account of the equitable considerations referred to above in this subsection
(D). For purposes of this paragraph, the relative benefits to the Company, on the one hand, and to the Placement Agent on the
other hand, of the matters contemplated by this Agreement shall be deemed to be in the same proportion as: (a) the total value
received by the Company in the Offering, whether or not such Offering is consummated, bears to (b) the commissions paid to the
Placement Agent under this Agreement. Notwithstanding the above, no person guilty of fraudulent misrepresentation within the meaning
of Section 11(f) of the Securities Act shall be entitled to contribution from a party who was not guilty of fraudulent misrepresentation.

 

    	 

     

    

 

9.5
Survival. The advancement, reimbursement, indemnity and contribution obligations set forth in this Section 9 shall remain
in full force and effect regardless of any termination of, or the completion of any Indemnified Person’s services under
or in connection with, this Agreement.

 

10.
Limitation of Placement Agent’s Liability to the Company.

 

The
Placement Agent and the Company further agree that neither the Placement Agent nor any of its affiliates or any of its respective
officers, directors, controlling persons (within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange
Act), employees or agent shall have any liability to the Company, its security holders or creditors, or any person asserting claims
on behalf of or in the right of the Company (whether direct or indirect, in contract or tort, for an act of negligence or otherwise)
for any losses, fees, damages, liabilities, costs, expenses or equitable relief arising out of or relating to this Agreement or
the Services rendered hereunder, except for losses, fees, damages, liabilities, costs or expenses that arise out of or are based
on any action of or failure to act by the Placement Agent and that are finally judicially determined to have resulted solely from
the gross negligence or willful misconduct of the Placement Agent.

 

11.
Limitation of Engagement to the Company.

 

The
Company acknowledges that the Placement Agent has been retained only by the Company, that the Placement Agent is providing services
hereunder as an independent contractor (and not in any fiduciary or agency capacity) and that the Company’s engagement of
the Placement Agent is not deemed to be on behalf of, and is not intended to confer rights upon, any shareholder, owner or partner
of the Company or any other person not a party hereto as against the Placement Agent or any of its affiliates, or any of its or
their respective officers, directors, controlling persons (within the meaning of Section 15 of the Securities Act or Section 20
of the Exchange Act), employees or agent. Unless otherwise expressly agreed in writing by the Placement Agent, no one other than
the Company is authorized to rely upon any statement or conduct of the Placement Agent in connection with this Agreement. The
Company acknowledges that any recommendation or advice, written or oral, given by the Placement Agent to the Company in connection
with the Placement Agent’s engagement is intended solely for the benefit and use of the Company’s management and directors
in considering a possible Offering, and any such recommendation or advice is not on behalf of, and shall not confer any rights
or remedies upon, any other person or be used or relied upon for any other purpose. The Placement Agent shall not have the authority
to make any commitment binding on the Company. The Company, in its sole discretion, shall have the right to reject any investor
introduced to it by the Placement Agent.

 

12.
Amendments and Waivers.

 

No
supplement, modification or waiver of this Agreement shall be binding unless executed in writing by the party to be bound thereby.
The failure of a party to exercise any right or remedy shall not be deemed or constitute a waiver of such right or remedy in the
future. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other provision
hereof (regardless of whether similar), nor shall any such waiver be deemed or constitute a continuing waiver unless otherwise
expressly provided.

 

13.
Confidentiality.

 

In
the event of the consummation or public announcement of any Offering, the Placement Agent shall have the right to disclose its
participation in such Offering, including, without limitation, the placement at its cost of “tombstone” advertisements
in financial and other newspapers and journals. The Placement Agent agrees not to use any confidential information concerning
the Company provided to the Placement Agent by the Company for any purposes other than those contemplated under this Agreement.

 

14.
Headings.

 

The
headings of the various sections of this Agreement have been inserted for convenience of reference only and will not be deemed
to be part of this Agreement.

 

    	 

     

    

 

15.
Counterparts.

 

This
Agreement may be executed in one or more counterparts and, if executed in more than one counterpart, the executed counterparts
shall each be deemed to be an original and all such counterparts shall together constitute one and the same instrument.

 

16.
Severability.

 

In
case any provision contained in this Agreement should be invalid, illegal or unenforceable in any respect, the validity, legality
and enforceability of the remaining provisions contained herein will not in any way be affected or impaired thereby.

 

17.
Use of Information.

 

The
Company has furnished the Placement Agent such written information as the Placement Agent reasonably requests in connection with
the performance of its services hereunder. The Company understands, acknowledges and agrees that, in performing its services hereunder,
the Placement Agent will use and rely entirely upon such information as well as publicly available information regarding the Company
and other potential parties to an Offering and that the Placement Agent do not assume responsibility for independent verification
of the accuracy or completeness of any information, whether publicly available or otherwise furnished to it, concerning the Company
or otherwise relevant to an Offering, including, without limitation, any financial information, forecasts or projections considered
by the Placement Agent in connection with the provision of its services.

 

18.
Absence of Fiduciary Relationship.

 

The
Company acknowledges and agrees that: (a) the Placement Agent has been retained solely to act as Placement Agent in connection
with the sale of the Securities and that no fiduciary, advisory or agency relationship between the Company and the Placement Agent
have been created in respect of any of the transactions contemplated by this Agreement, irrespective of whether the Placement
Agent has advised or are advising the Company on other matters and that the Placement Agent owes the Company only those duties
and obligations set forth in this Agreement; (b) the Share Purchase Price and other terms of the Securities set forth in this
Agreement were established by the Company following discussions and arms-length negotiations with the Placement Agent and the
Company is capable of evaluating and understanding and understands and accepts the terms, risks and conditions of the transactions
contemplated by this Agreement; (c) it has been advised that the Placement Agent and its affiliates are engaged in a broad range
of transactions that may involve interests that differ from those of the Company and that the Placement Agent has no obligation
to disclose such interest and transactions to the Company by virtue of any fiduciary, advisory or agency relationship; and (d)
it has been advised that the Placement Agent are acting, in respect of the transactions contemplated by this Agreement, solely
for the benefit of the Placement Agent, and not on behalf of the Company and that the Placement Agent may have interests that
differ from those of the Company. The Company waives to the full extent permitted by applicable law any claims it may have against
the Placement Agent arising from an alleged breach of fiduciary duty in connection with the Offering.

 

19.
Survival of Indemnities, Representations, Warranties, Etc.

 

The
respective indemnities, covenants, agreements, representations, warranties and other statements of the Company and Placement Agent,
as set forth in this Agreement or made by them respectively, pursuant to this Agreement, shall remain in full force and effect,
regardless of any investigation made by or on behalf of the Placement Agent, the Company, the Purchasers or any person controlling
any of them and shall survive delivery of and payment for the Securities. Notwithstanding any termination of this Agreement, including
without limitation any termination pursuant to Section 5, the payment, reimbursement, indemnity, contribution and advancement
agreements contained in Sections 2, 9, 10, and 11, respectively, and the Company’s covenants, representations, and warranties
set forth in this Agreement shall not terminate and shall remain in full force and effect at all times. The indemnity and contribution
provisions contained in Section 9 and the covenants, warranties and representations of the Company contained in this Agreement
shall remain operative and in full force and effect regardless of (i) any termination of this Agreement, (ii) any investigation
made by or on behalf of any Placement Agent, any person who controls any Placement Agent within the meaning of either Section
15 of the Securities Act or Section 20 of the Exchange Act or any affiliate of any Placement Agent, or by or on behalf of the
Company, its directors or officers or any person who controls the Company within the meaning of either Section 15 of the Securities
Act or Section 20 of the Exchange Act, and (iii) the issuance and delivery of the Securities.

 

    	 

    	 

    

 

20.
Governing Law.

 

This
Agreement shall be governed by and construed in accordance with the laws of the State of New York applicable to agreements made
and to be fully performed therein. Any disputes that arise under this Agreement, even after the termination of this Agreement,
will be heard only in the state or federal courts located in the City of New York, State of New York. The parties hereto expressly
agree to submit themselves to the jurisdiction of the foregoing courts in the City of New York, State of New York. The parties
hereto expressly waive any rights they may have to contest the jurisdiction, venue or authority of any court sitting in the City
and State of New York.

 

21.
Notices.

 

All
communications hereunder shall be in writing and shall be mailed, hand delivered or faxed and confirmed to the parties hereto
as follows:

 

If
to the Company:

 

Greenpro
Capital Corp.

Room
1701-03, 17/F, The Metropolis Tower,

10
Metropolis Drive, Hung Hom,

Kowloon,
Hong Kong

Attention:
Chief Executive Officer

Facsimile:
+852 3111 7720

E-mail:
admin@greenprocapital.com

 

with
a copy to:

 

Loeb & Loeb LLP

345
Park Avenue, 19th Floor

New
York, NY 10154

Attention:
Mitchell S. Nussbaum, Esq.

Facsimile:
212-407-4990

Email:
mnussbaum@loeb.com

 

If
to the Placement Agent:

 

Network
1 Financial Securities, Inc.

2
Bridge Avenue, Penthouse

Red
Bank, NJ 07701

Attention:
Damon Testaverde

Facsimile:
732-758-6671

E-mail:
ddtestaverde@netw1.com

 

with
a copy to:

 

Mei & Mark LLP

818
18th Street NW, Suite 410

Washington,
DC 20006

Attention:
Fang Liu

Facsimile:
888-706-1173

Email:
fliu@meimark.com

 

Any
party hereto may change the address for receipt of communications by giving written notice to the others.

 

    	 

    	 

    

 

22.
Miscellaneous.

 

This
Agreement shall not be modified or amended except in writing signed by the Placement Agent and the Company. This Agreement constitutes
the entire agreement of the Placement Agent and the Company, and supersedes any prior agreements, with respect to the subject
matter hereof. If any provision of this Agreement is determined to be invalid or unenforceable in any respect, such determination
will not affect such provision in any other respect, and the remainder of this Agreement shall remain in full force and effect.
This Agreement may be executed in counterparts (including facsimile or .pdf counterparts), each of which shall be deemed an original
but all of which together shall constitute one and the same instrument.

 

23.
Successors.

 

This
Agreement will inure to the benefit of and be binding upon the parties hereto, and to the benefit of the employees, officers and
directors and controlling persons referred to in Section 9 hereof, and to their respective successors, and personal representative,
and, except as set forth in Section 9 of this Agreement, no other person will have any right or obligation hereunder.

 

24.
Partial Unenforceability.

 

The
invalidity or unenforceability of any section, paragraph or provision of this Agreement shall not affect the validity or enforceability
of any other section, paragraph or provision hereof. If any Section, paragraph or provision of this Agreement is for any reason
determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and only such minor changes) as
are necessary to make it valid and enforceable.

 

[SIGNATURE
PAGE FOLLOWS]

 

    	 

    	 

    

 

If
the foregoing correctly sets forth the understanding between the Placement Agent and the Company, please so indicate in the space
provided below for that purpose, whereupon this letter shall constitute a binding agreement between us.

 

	 	Very
    truly yours,
	 	 
	 	GREENPRO
    CAPITAL CORP.
	 	 
	 	By:	/s/
    Lee Chong Kuang
	 	Name:	Lee Chong Kuang
	 	Title:	Chief Executive
    Officer

 

	Accepted
    on the date first above written.	 

 

	NETWORK
    1 FINANCIAL SECURITIES, INC.
	 
	By:	/s/
    Adam Pasholk	 
	Name:	Adam
    Pasholk
	Title:	Managing
    Director

 

    	 

    	 

    

 

EXHIBIT
A

 

Form
of Placement Agent’s Warrant

 

    	 

    	 

    

 

THE
REGISTERED HOLDER OF THIS PLACEMENT AGENT’S WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR
ASSIGN THIS PLACEMENT AGENT’S WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PLACEMENT AGENT’S
WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PLACEMENT AGENT’S WARRANT OR CAUSE IT
TO BE THE SUBJECT OF ANY HEDGING, SHORT SALE, DERIVATIVE, PUT, OR CALL TRANSACTION THAT WOULD RESULT IN THE EFFECTIVE ECONOMIC
DISPOSITION OF THE PLACEMENT AGENT WARRANT BY ANY PERSON FOR A PERIOD BEGINNING FROM THE EFFECTIVENESS OF THE REGISTRATION STATEMENT
(DEFINED BELOW) UNTIL 180 DAYS AFTER THE EFFECTIVE DATE OF THE OFFERING TO ANYONE OTHER THAN (I) NETWORK 1 FINANCIAL SECURITIES,
INC. (“NETWORK 1”) OR AN PLACEMENT AGENT OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE
OFFICER OR PARTNER OF NETWORK 1 OR OF ANY SUCH PLACEMENT AGENT OR SELECTED DEALER AND IN ACCORDANCE WITH FINRA RULE 5110(G)(2).

 

PLACEMENT
AGENT’S WARRANT

 

Warrant
Certificate No: ___

 

Original
Issue Date: ___

 

For
the Purchase of

 

___
Shares

 

of

 

GREENPRO
CAPITAL CORP.

 

1.
Placement Agent’s Warrant.

 

THIS CERTIFIES THAT, for value received, [NAME
OF HOLDER], a [JURISDICTION AND TYPE OF ENTITY], or its registered assigns (“Holder”), as registered owner of this
Placement Agent’s Warrant, to GREENPRO CAPITAL CORP. (“Company”), Holder is entitled, at any time or from time
to time from ______, 2018 (six months after the effective date of the offering (the “Offering”), as set forth
in the Company’s registration statement on Form S-1 (No. 333-219625) (the “Registration Statement”) (the “Expiration
Date”), and at or before 5:00 p.m., Eastern Time, ____________, 2022, (the five-year anniversary of the effective date of
the Offering) but not thereafter, to subscribe for, purchase and receive, in whole or in part, up to ___ (___) Shares of the Company.
If the Expiration Date is a day on which banking institutions are authorized by law to close, then this Placement Agent’s
Warrant may be exercised on the next succeeding day which is not such a day in accordance with the terms herein. During the period
ending on the Expiration Date, the Company agrees not to take any action that would terminate the Placement Agent’s Warrant.
This Placement Agent’s Warrant is initially exercisable at $7.20 per Share (120% of the price of the Shares at the
effective date of the Offering) so purchased; provided, however, that upon the occurrence of any of the events specified in Section
6 hereof, the rights granted by this Placement Agent’s Warrant, including the exercise price per share and the number of
Shares to be received upon such exercise, shall be adjusted as therein specified. The term “Exercise Price” shall
mean the initial exercise price or the adjusted exercise price, depending on the context.

 

    	 

    	 

    

 

2.
Exercise.

 

2.1
Exercise Form. In order to exercise this Placement Agent’s Warrant, the exercise form attached hereto must be duly
executed and completed and delivered to the Company, together with this Placement Agent’s Warrant and payment of the Exercise
Price for the Share being purchased payable in cash or by certified check or official bank check. If the subscription rights represented
hereby shall not be exercised at or before 5:00 p.m., Eastern Time, on the Expiration Date, this Placement Agent’s Warrant
shall become and be void without further force or effect, and all rights represented hereby shall cease and expire.

 

2.2
Legend. Each certificate for the securities purchased under this Placement Agent’s Warrant shall bear a legend as
follows unless such securities have been registered under the Securities Act of 1933, as amended (“Act”):

 

“The
securities represented by this certificate have not been registered under the Securities Act of 1933, as amended (“Act”)
or applicable state law. The securities may not be offered for sale, sold or otherwise transferred except pursuant to an effective
registration statement under the Act, or pursuant to an exemption from registration under the Act and applicable state law.”

 

2.3
Cashless Exercise.

 

2.3.1
Determination of Amount. In lieu of the payment of the Exercise Price multiplied by the number of Shares for which this
Placement Agent’s Warrant is exercisable in the manner required by Section 2.1, the Holder shall have the right (but not
the obligation) to convert any exercisable but unexercised portion of this Placement Agent’s Warrant into Shares (“Conversion
Right”). Upon a “cashless exercise”, the Holder shall surrender this Warrant to the Company, together with the
Election to Purchase, and the Company shall issue to the Holder the number of Shares determined as follows:

 

	 	X
    = Y (A-B)/A
	 	 	 	 
	 	where:	 	 
	 	 	 	 
	 	X	=	The
    number of Shares to be issued to the Holder.
	 	 	 	 
	 	Y	=	The
    number of Shares with respect to which this Warrant is being exercised.
	 	 	 	 
	 	A	=	The
    fair market value of one Share.
	 	 	 	 
	 	B	=	The
    Exercise Price.

 

    	 

    	 

    

 

For
purposes of this Section 2.3, the fair market value of one Share shall be determined by the first of the following clauses
that applies:

 

(i)
if the Common Stock is traded on a national securities exchange, the fair market value shall be the last sale price on the trading
day immediately prior to the Date of Exercise or, if no sale of the Company’s Common Stock took place on the trading day
immediately prior to the Date of Exercise, then the fair market value shall be the last sale price on the most recent day prior
to the Date of Exercise on which trades were made and reported;

 

(ii)
if the Common Stock is traded over-the-counter, the fair market value shall be deemed to be the last sale price on the trading
day immediately prior to the Date of Exercise or, if no sale of the Company’s Common Stock took place on the trading day
immediately prior to the Date of Exercise, then the fair market value shall be the last sale price on the most recent day prior
to the Date of Exercise on which trades were made and reported; or

 

(iii)
if there is no active public market for the Common Stock, the fair market value thereof shall be determined in good faith by the
Company’s Board of Directors (the “Board”).

 

(a)
For purposes of Rule 144 of the Act, it is intended, understood and acknowledged that the t Shares issued in a cashless exercise
transaction shall be deemed to have been acquired by the Holder, and the holding period for the Shares shall be deemed to have
been commenced, on the Issuance Date.

 

2.3.2
Mechanics of Cashless Exercise. The Cashless Exercise Right may be exercised by the Holder on any business day on or after
the Commencement Date and not later than the Expiration Date by delivering the Placement Agent’s Warrant with a duly executed
exercise form attached hereto with the cashless exercise section completed to the Company, exercising the Cashless Exercise Right
and specifying the total number of Shares the Holder will purchase pursuant to such Cashless Exercise Right.

 

2.4
No Obligation to Net Cash Settle. Notwithstanding anything to the contrary contained in this Placement Agent Warrant, in
no event will the Company be required to net cash settle the exercise of the Placement Agent Warrant. The holder of the Placement
Agent Warrant will not be entitled to exercise the Placement Agent Warrant unless it exercises such Purchase Warrant pursuant
to the cashless exercise right or a registration statement is effective, or an exemption from the registration requirements is
available at such time and, if the Holder is not able to exercise the Placement Agent Warrant, the Placement Agent Warrant will
expire worthless.

 

3.
Transfer.

 

3.1
General Restrictions. The registered Holder of this Placement Agent’s Warrant agrees that it will not sell, transfer,
assign, pledge or hypothecate this Placement Agent’s Warrant, or any portion thereof, or be the subject of any hedging,
short sale, derivative, put or call transaction that would result in the effective economic disposition of such securities for
a period beginning from the effectiveness of the Registration Statement until 180 days after the effective date of the Offering
to anyone other than (i) NETWORK 1 or an Placement Agent or a selected dealer participating in the Offering, or (ii) a bona fide
officer or partner of NETWORK 1 or of any such Placement Agent or selected dealer. After a period of 180 days following the effective
date of the Offering, transfers to others may be made subject to compliance with or exemptions from applicable securities laws.
In order to make any permitted assignment, the Holder must deliver to the Company the assignment form attached hereto duly executed
and completed, together with the Placement Agent’s Warrant and payment of all transfer taxes, if any, payable in connection
therewith. The Company shall within five business days transfer this Placement Agent’s Warrant on the books of the Company
and shall execute and deliver a new Placement Agent’s Warrant or Placement Agent’s Warrants of like tenor to the appropriate
assignee(s) expressly evidencing the right to purchase the aggregate number of Shares purchasable hereunder or such portion of
such number as shall be contemplated by any such assignment.

 

    	 

    	 

    

 

3.2
Restrictions Imposed by the Act. The securities evidenced by this Placement Agent’s Warrant shall not be transferred
unless and until (i) the Company has received the opinion of counsel for the Holder that the securities may be transferred pursuant
to an exemption from registration under the Act and applicable state securities laws, the availability of which is established
to the reasonable satisfaction of the Company (the Company hereby agreeing that the opinion of Mei & Mark LLP shall be deemed
satisfactory evidence of the availability of an exemption), or (ii) a registration statement or a post-effective amendment to
the Registration Statement relating to the offer and sale of such securities has been filed by the Company and declared effective
by the Securities and Exchange Commission and compliance with applicable state securities law has been established.

 

4.
New Placement Agent’s Warrants to be Issued.

 

4.1
Partial Exercise or Transfer. Subject to the restrictions in Section 3 hereof, this Placement Agent’s Warrant may
be exercised or assigned in whole or in part. In the event of the exercise or assignment hereof in part only, upon surrender of
this Placement Agent’s Warrant for cancellation, together with the duly executed exercise or assignment form and funds sufficient
to pay any Exercise Price and/or transfer tax if exercised pursuant to Section 2.1 hereto, the Company shall cause to be delivered
to the Holder without charge a new Placement Agent’s Warrant of like tenor to this Placement Agent’s Warrant in the
name of the Holder evidencing the right of the Holder to purchase the number of Shares purchasable hereunder as to which this
Placement Agent’s Warrant has not been exercised or assigned.

 

4.2
Lost Certificate. Upon receipt by the Company of evidence satisfactory to it of the loss, theft, destruction or mutilation
of this Placement Agent’s Warrant and of reasonably satisfactory indemnification or the posting of a bond, the Company shall
execute and deliver a new Placement Agent’s Warrant of like tenor and date. Any such new Placement Agent’s Warrant
executed and delivered as a result of such loss, theft, mutilation or destruction shall constitute a substitute contractual obligation
on the part of the Company.

 

5.
Registration Rights. The Company has filed the Registration Statement, including a related prospectus, with the Securities
and Exchange Commission, which has been declared effective on Form S-1 (File No. 333-219625). The Registration Statement registers
the Shares.

 

5.1
General Terms.

 

5.1.1
Indemnification. The Company shall indemnify the Holder(s) of the Registrable Securities to be sold pursuant to any registration
statement hereunder and each person, if any, who controls such Holders within the meaning of Section 15 of the Act or Section
20(a) of the Securities Exchange Act of 1934, as amended (“Exchange Act”), against all loss, claim, damage, expense
or liability (including all reasonable attorneys’ fees and other expenses reasonably incurred in investigating, preparing
or defending against litigation, commenced or threatened, or any claim whatsoever) to which any of them may become subject under
the Act, the Exchange Act or otherwise, arising from such registration statement but only to the same extent and with the same
effect as the provisions pursuant to which the Company has agreed to indemnify the Placement Agents contained in Section 5 of
the Placement Agency Agreement in the Offering. The Holder(s) of the Registrable Securities to be sold pursuant to such registration
statement, and their successors and assigns, shall severally, and not jointly, indemnify the Company, its officers and directors
and each person, if any, who controls the Company within the meaning of Section 15 of the Act or Section 20(a) of the Exchange
Act, against all loss, claim, damage, expense or liability (including all reasonable attorneys’ fees and other expenses
reasonably incurred in investigating, preparing or defending against any claim whatsoever) to which they may become subject under
the Act, the Exchange Act or otherwise, arising from information furnished by or on behalf of such Holders, or their successors
or assigns, in writing, for specific inclusion in such registration statement to the same extent and with the same effect as the
provisions contained in Section 5 of the Placement Agency Agreement pursuant to which the Placement Agents have agreed to indemnify
the Company.

 

5.1.2
Exercise of Placement Agent’s Warrants. Nothing contained in this Placement Agent’s Warrant shall be construed
as requiring the Holder(s) to exercise their Placement Agent’s Warrants prior to or after the initial filing of any registration
statement or the effectiveness thereof.

 

5.1.5
Rule 144 Sale. Notwithstanding anything contained in this Section 5 to the contrary, the Company shall have no obligation
to maintain the effectiveness of the Registration Statement covering the Shares held by any Holder, where such Holder would then
be entitled to sell under Rule 144 within any three-month period (or such other period prescribed under Rule 144 as may be provided
by amendment thereof) all of the Registrable Securities then held by such Holder.

 

    	 

    	 

    

 

5.1.6
Supplemental Prospectus. Each Holder agrees, that upon receipt of any notice from the Company of the happening of any event
as a result of which the prospectus included in the Registration Statement, as then in effect, includes an untrue statement of
a material fact or omits to state a material fact required to be stated therein or necessary to make the statements therein not
misleading in light of the circumstances then existing, or that would otherwise require disclosure of material nonpublic information
that, if disclosed at such time, would be materially harmful to the Company, such Holder will immediately discontinue disposition
of Registrable Securities pursuant to the Registration Statement covering such Registrable Securities until such Holder’s
receipt of the copies of a supplemental or amended prospectus, or the public disclosure and dissemination of such information,
as the case may be, and, if so desired by the Company, such Holder shall deliver to the Company (at the expense of the Company)
or destroy (and deliver to the Company a certificate of such destruction) all copies, other than permanent file copies then in
such Holder’s possession, of the prospectus covering such Registrable Securities current at the time of receipt of such
notice.

 

6.
Adjustments.

 

6.1
Adjustments to Exercise Price and Number of Securities. The Exercise Price and the number of Shares underlying the Placement
Agent’s Warrant shall be subject to adjustment from time to time as hereinafter set forth:

 

6.1.1
Stock Dividends; Split Ups. If after the date hereof, and subject to the provisions of Section 6.3 below, the number of
outstanding shares of Common Stock is increased by a stock dividend payable in shares of Common Stock or by a split up of shares
of Common Stock or other similar event, then, on the effective day thereof, the number of Shares purchasable hereunder shall be
increased in proportion to such increase in outstanding shares of Common Stock. For example, if the Company declares a two-for-one
stock dividend and at the time of such dividend this Placement Agent’s Warrant is for the purchase of one Share at $6.25
per Share, upon effectiveness of the dividend, this Placement Agent’s Warrant will be adjusted to allow for the purchase
of one Share for $3.125. In such example, the number of Shares purchasable hereunder would be doubled.

 

6.1.2
Aggregation of Shares. If after the date hereof, and subject to the provisions of Section 6.3, the number of outstanding
shares of Common Stock is decreased by a consolidation, combination or reclassification of Shares or other similar event, then,
on the effective date thereof, the number of Shares underlying this Placement Agent’s Warrant each of purchasable hereunder
shall be decreased in proportion to such decrease in outstanding shares.

 

6.1.3
Replacement of Securities upon Reorganization, etc. In case of any reclassification or reorganization of the outstanding
shares of Common Stock other than a change covered by Section 6.1.1 or 6.1.2 hereof or that solely affects the par value of the
shares of Common Stock, or in the case of any merger or consolidation of the Company with or into another corporation (other than
a consolidation or merger in which the Company is the continuing corporation and that does not result in any reclassification
or reorganization of the outstanding shares of Common Stock, or in the case of any sale or conveyance to another corporation or
entity of the property of the Company as an entirety or substantially as an entirety in connection with which the Company is dissolved,
the Holder of this Placement Agent’s Warrant shall have the right thereafter (until the expiration of the right of exercise
of this Placement Agent’s Warrant) to receive upon the exercise hereof, for the same aggregate Exercise Price payable hereunder
immediately prior to such event, the kind and amount of shares of stock or other securities or property (including cash) receivable
upon such reclassification, reorganization, merger or consolidation, or upon a dissolution following any such sale or transfer,
by a Holder of the number of shares of Common Stock of the Company obtainable upon exercise of this Placement Agent’s Warrant
immediately prior to such event; and if any reclassification also results in a change in the number of shares of Common Stock
covered by Section 6.1.1 or 6.1.2, then such adjustment shall be made pursuant to Sections 6.1.1, 6.1.2 and this Section 6.1.3.
The provisions of this Section 6.1.3 shall similarly apply to successive reclassifications, reorganizations, mergers or consolidations,
sales or other transfers.

 

6.1.4
Changes in Form of Placement Agent’s Warrant. This form of Placement Agent’s Warrant need not be changed because
of any change pursuant to this Section, and Placement Agent’s Warrants issued after such change may state the same Exercise
Price and the same number of Shares are stated in the Placement Agent’s Warrants initially issued pursuant to this Agreement.
The acceptance by any Holder of the issuance of new Placement Agent’s Warrant reflecting a required or permissive change
shall not be deemed to waive any rights to an adjustment occurring after the Commencement Date or the computation thereof.

 

    	 

    	 

    

 

6.2
Substitute Placement Agent’s Warrant. In case of any consolidation of the Company with, or merger of the Company
with or into, another corporation (other than a consolidation or merger which does not result in any reclassification or change
of the outstanding Shares), the corporation formed by such consolidation or merger shall execute and deliver to the Holder a supplemental
Placement Agent’s Warrant providing that the holder of each Placement Agent’s Warrant then outstanding or to be outstanding
shall have the right thereafter (until the stated expiration of such Placement Agent’s Warrant) to receive, upon exercise
of such Placement Agent’s Warrant, the kind and amount of Shares and other securities and property receivable upon such
consolidation or merger, by a holder of the number of Shares of the Company for which such Placement Agent’s Warrant might
have been exercised immediately prior to such consolidation, merger, sale or transfer. Such supplemental Placement Agent’s
Warrant shall provide for adjustments which shall be identical to the adjustments provided in Section 6. The above provision of
this Section shall similarly apply to successive consolidations or mergers.

 

6.3
Elimination of Fractional Interests. The Company shall not be required to issue certificates representing fractions of
Shares upon the exercise of the Placement Agent’s Warrant, nor shall it be required to issue scrip or pay cash in lieu of
any fractional interests, it being the intent of the parties that all fractional interests shall be eliminated by rounding any
fraction up to the nearest whole number of Warrants, Shares or other securities, properties or rights.

 

7.
Reservation and Listing. The Company shall at all times reserve and keep available out of its authorized Shares, solely
for the purpose of issuance upon exercise of the Placement Agent’s Warrants, such number of shares of Shares, or other securities,
properties or rights as shall be issuable upon the exercise thereof. The Company covenants and agrees that, upon exercise of the
Placement Agent’s Warrants and payment of the Exercise Price therefor, in accordance with the terms hereby, all Shares and
other securities issuable upon such exercise shall be duly and validly issued, fully paid and non-assessable and not subject to
preemptive rights of any stockholder. As long as the Placement Agent’s Warrants shall be outstanding, the Company shall
use its commercially reasonable efforts to cause all Shares issuable upon exercise of the Placement Agent’s Warrants, to
be listed (subject to official notice of issuance) on all securities exchanges on which the Shares, issued to the public in the
Offering may then be listed and/or quoted.

 

8.
Certain Notice Requirements.

 

8.1
Holder’s Right to Receive Notice. Nothing herein shall be construed as conferring upon the Holders the right to vote
or consent or to receive notice as a stockholder for the election of directors or any other matter, or as having any rights whatsoever
as a stockholder of the Company. If, however, at any time prior to the expiration of the Placement Agent’s Warrants and
their exercise, any of the events described in Section 8.2 shall occur, then, in one or more of said events, the Company shall
give written notice of such event at least fifteen days prior to the date fixed as a record date or the date of closing the transfer
books for the determination of the stockholders entitled to such dividend, distribution, conversion or exchange of securities
or subscription rights, or entitled to vote on such proposed dissolution, liquidation, winding up or sale. Such notice shall specify
such record date or the date of the closing of the transfer books, as the case may be. Notwithstanding the foregoing, the Company
shall deliver to each Holder a copy of each notice given to the other stockholders of the Company at the same time and in the
same manner that such notice is given to the stockholders.

 

8.2
Events Requiring Notice. The Company shall be required to give the notice described in this Section 8 upon one or more
of the following events: (i) if the Company shall take a record of the holders of its Shares for the purpose of entitling them
to receive a dividend or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise than
out of retained earnings, as indicated by the accounting treatment of such dividend or distribution on the books of the Company,
(ii) the Company shall offer to all the holders of its Shares any additional Shares of the Company or securities convertible into
or exchangeable for Shares of the Company, or any option, right or warrant to subscribe therefor, or (iii) a dissolution, liquidation
or winding up of the Company (other than in connection with a consolidation or merger) or a sale of all or substantially all of
its property, assets and business shall be proposed.

 

    	 

    	 

    

 

8.3
Notice of Change in Exercise Price. The Company shall, promptly after an event requiring a change in the Exercise Price
pursuant to Section 6 hereof, send notice to the Holders of such event and change (“Price Notice”). The Price Notice
shall describe the event causing the change and the method of calculating same and shall be certified as being true and accurate
by the Company’s Chief Financial Officer.

 

8.4
Transmittal of Notices. All notices, requests, demands and other communications which are required or may be given under
this Placement Agent’s Warrant shall be in writing and shall be deemed to have been duly given: (a) when received, if personally
delivered; (b) when transmitted, if transmitted by telecopy, electronic or digital transmission method with confirmation of transmission
by the transmitting equipment; (c) the day after it is sent, if sent for next day delivery to a domestic address by a recognized
overnight delivery service (e.g., Federal Express); and (d) upon receipt, if sent by certified or registered mail, return
receipt requested. In each case, notice shall be sent to the parties at the following address (or to such other address as a party
may have specified by notice given to the other party pursuant to this provision):

 

Greenpro
Capital Corp.

Room
1701-03, 17/F, The Metropolis Tower

10
Metropolis Drive, Hung Hom,

Kowloon,
Hong Kong

Attention:
Chief Executive Officer

Facsimile:
+852 3111 7720

E-mail:
admin@greenprocapital.com

 

with
a copy to:

 

Loeb & Loeb LLP

345
Park Avenue, 19th Floor

New
York, NY 10154

Attention:
Mitchell S. Nussbaum, Esq.

Facsimile:
212-407-4990

Email:
mnussbaum@loeb.com

 

9.
Miscellaneous.

 

9.1
Amendments. The Company and NETWORK 1 may from time to time supplement or amend this Placement Agent’s Warrant without
the approval of any of the Holders in order to cure any ambiguity, to correct or supplement any provision contained herein that
may be defective or inconsistent with any other provisions herein, or to make any other provisions in regard to matters or questions
arising hereunder that the Company and NETWORK 1 may deem necessary or desirable and that the Company and NETWORK 1 deem shall
not adversely affect the interest of the Holders. All other modifications or amendments shall require the written consent of and
be signed by the party against whom enforcement of the modification or amendment is sought.

 

9.2
Headings. The headings contained herein are for the sole purpose of convenience of reference, and shall not in any way
limit or affect the meaning or interpretation of any of the terms or provisions of this Placement Agent’s Warrant.

 

10.
Entire Agreement. This Placement Agent’s Warrant (together with the other agreements and documents being delivered
pursuant to or in connection with this Placement Agent’s Warrant) constitutes the entire agreement of the parties hereto
with respect to the subject matter hereof, and supersedes all prior agreements and understandings of the parties, oral and written,
with respect to the subject matter hereof.

 

10.1
Binding Effect. This Placement Agent’s Warrant shall inure solely to the benefit of and shall be binding upon, the
Holder and the Company and their permitted assignees, respective successors, legal representative and assigns, and no other person
shall have or be construed to have any legal or equitable right, remedy or claim under or in respect of or by virtue of this Placement
Agent’s Warrant or any provisions herein contained.

 

    	 

    	 

    

 

10.2
Governing Law; Submission to Jurisdiction. This Placement Agent’s Warrant shall be governed by and construed and
enforced in accordance with the laws of the State of New York, without giving effect to conflict of laws. The Company hereby agrees
that any action, proceeding or claim against it arising out of, or relating in any way to this Placement Agent’s Warrant
shall be brought and enforced in the courts of the State of New York or of the United States of America for the Southern District
of New York, and irrevocably submits to such jurisdiction, which jurisdiction shall be exclusive. The Company hereby waives any
objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Any process or summons to be served
upon the Company may be served by transmitting a copy thereof by registered or certified mail, return receipt requested, postage
prepaid, addressed to it at the address set forth in Section 8 hereof. Such mailing shall be deemed personal service and shall
be legal and binding upon the Company in any action, proceeding or claim. The Company and the Holder agree that the prevailing
party(ies) in any such action shall be entitled to recover from the other party(ies) all of its reasonable attorneys’ fees
and expenses relating to such action or proceeding and/or incurred in connection with the preparation therefor.

 

10.3
Waiver, Etc. The failure of the Company or the Holder to at any time enforce any of the provisions of this Placement Agent’s
Warrant shall not be deemed or construed to be a waiver of any such provision, nor to in any way affect the validity of this Placement
Agent’s Warrant or any provision hereof or the right of the Company or any Holder to thereafter enforce each and every provision
of this Placement Agent’s Warrant. No waiver of any breach, non-compliance or non-fulfillment of any of the provisions of
this Placement Agent’s Warrant shall be effective unless set forth in a written instrument executed by the party or parties
against whom or which enforcement of such waiver is sought; and no waiver of any such breach, non-compliance or non-fulfillment
shall be construed or deemed to be a waiver of any other or subsequent breach, non-compliance or non-fulfillment.

 

10.4
Execution in Counterparts. This Placement Agent’s Warrant may be executed in one or more counterparts, and by the
different parties hereto in separate counterparts, each of which shall be deemed to be an original, but all of which taken together
shall constitute one and the same agreement, and shall become effective when one or more counterparts has been signed by each
of the parties hereto and delivered to each of the other parties hereto.

 

[Remainder
of page deliberately left blank]

 

    	 

    	 

    

 

IN WITNESS WHEREOF, the
Company has caused this Placement Agent’s Warrant to be signed by its duly authorized officer as of the ____ day
of ________, 2018.

 

	 	GREENPRO
    CAPITAL CORP.
	 	 	 
	 	By:	
	 	Name:	Lee
    Chong Kuang
	 	Its:	Chief
    Executive Officer

 

    	 

    	 

    

 

Form
to be used to exercise Placement Agent’s Warrant:

 

Greenpro
Capital Corp.

Room
1701-03, 17/F, The Metropolis Tower

10
Metropolis Drive, Hung Hom,

Kowloon,
Hong Kong

Attention:
Chief Executive Officer

 

Date:
_________________, 201__

 

The
undersigned hereby elects irrevocably to exercise the within Placement Agent’s Warrant and to purchase __________ Shares
of Greenpro Capital Corp. and hereby makes payment of $____________ (at the rate of $_________ per Share) in payment of the Exercise
Price pursuant thereto. Please issue the Shares as to which this Placement Agent’s Warrant is exercised in accordance with
the instructions given below.

 

or

 

The
undersigned hereby elects irrevocably to convert its right to purchase _________ Shares purchasable under the within Placement
Agent’s Warrant by surrender of the unexercised portion of the attached Placement Agent’s Warrant (with a “Value”
based of $_______ based on a “Market Price” of $_______). Please issue the Shares as to which this Placement Agent’s
Warrant is exercised in accordance with the instructions given below.

 

	 	 
	 	Signature
	 	 
	 	 
	 	Signature
    Guaranteed

 

    	 

    	 

    

 

INSTRUCTIONS
FOR REGISTRATION OF SECURITIES

 

Name:_____________________________________________________________

(Print
in Block Letters)

 

Address:___________________________________________________________

 

NOTICE:
The signature to this form must correspond with the name as written upon the face of the within Placement Agent’s Warrant
in every particular without alteration or enlargement or any change whatsoever, and must be guaranteed by a bank, other than a
savings bank, or by a trust company or by a firm having membership on a registered national securities exchange.

 

    	 

    	 

    

 

Form
to be used to assign Placement Agent’s Warrant:

 

ASSIGNMENT

 

(To
be executed by the registered Holder to effect a transfer of the within Placement Agent’s Warrant):

 

FOR
VALUE RECEIVED, _________________________ does hereby sell, assign and transfer unto_______________ the right to purchase __________
Shares of Greenpro Capital Corp. (“Company”) evidenced by the within Placement Agent’s Warrant and does hereby
authorize the Company to transfer such right on the books of the Company.

 

Dated:
___________________, 201

 

	 	 
	 	Signature
	 	 
	 	 
	 	Signature
    Guaranteed

 

NOTICE:
The signature to this form must correspond with the name as written upon the face of the within Placement Agent’s Warrant
in every particular without alteration or enlargement or any change whatsoever, and must be guaranteed by a bank, other than a
savings bank, or by a trust company or by a firm having membership on a registered national securities exchange.

 

    	 

    	 

    

 

EXHIBIT
B

 

Issuer
General Use Free Writing Prospectuses

 

    	 

    	 

    

 

EXHIBIT
C

 

Lock-Up
Agreement

 

___________
__, 20__

 

Network
1 Financial Securities, Inc.

2
Bridge Avenue, Penthouse

Red
Bank, NJ 07701

 

Ladies
and Gentlemen:

 

The
undersigned understands that Network 1 Financial Securities, Inc. (the “Placement Agent”) proposes to enter
into an Placement Agency Agreement (the “Placement Agency Agreement”) with Greenpro Capital Corp., a
Nevada corporation (the “Company”), providing for the public offering (the “Public Offering”)
by the Placement Agent named in the Placement Agency Agreement of minimum of 500,000 and maximum of 2,500,000 Shares of the Company.

 

To
induce the Placement Agent to continue its efforts in connection with the Public Offering, the undersigned hereby agrees that,
without the prior written consent of the Placement Agent, it will not, during the period commencing on the date hereof and ending
180 days after the effective date of the Offering (the “Lock-Up Period”), (1) offer, pledge, sell, contract
to sell, grant, lend, or otherwise transfer or dispose of, directly or indirectly, any capital stock of the Company including
shares of Company common stock (“Shares”) or any securities convertible into or exercisable or exchangeable
for capital stock, or (2) enter into any swap or other arrangement that transfers to another, in whole or in part, any of the
economic consequences of ownership of capital stock, whether any such transaction described in clause (1) or (2) above is to be
settled by delivery of Company capital stock or such other securities, in cash or otherwise. Notwithstanding the foregoing, the
undersigned may transfer Shares held by the undersigned without the prior consent of the Placement Agent in connection with (a)
transfers of Shares or any security convertible into Shares as a bona fide gift, by will or intestacy or to a family member or
trust for the benefit of a family member; provided that in the case of any transfer or distribution pursuant to clause
(a), (i) each donee or distributee shall sign and deliver a lock-up letter substantially in the form of this letter agreement
and (ii) no filing under Section 16(a) of the Exchange Act, reporting a reduction in beneficial ownership of Shares , shall be
required or shall be voluntarily made during the Lock-up Period, (b) transfer of Shares to a charity or educational institution,
or (c) if the undersigned, directly or indirectly, controls a corporation, partnership, limited liability company or other business
entity, any transfers of Shares to any shareholder, partner or member of, or owner of similar equity interests in, the undersigned,
as the case may be, if, in any such case, such transfer is not for value. In addition, the undersigned agrees that during the
Lock-Up Period, without the prior written consent of the Placement Agent, it will not make any demand for or exercise any right
with respect to the registration of any Shares or any security convertible into or exercisable or exchangeable for such Shares.
The undersigned also agrees and consents to the entry of stop transfer instructions with the Company’s transfer agent(s)
and/or registrar against the transfer of the undersigned’s securities or Shares except in compliance with this Agreement.

 

If
(i) the Company issues an earnings release or material news, during the last 17 days of the Lock-Up Period, or (ii) prior to the
expiration of the Lock-Up Period, the Company announces that it will release earnings results during the 16-day period beginning
on the last day of the Lock-Up Period, the restrictions imposed by this agreement shall continue to apply until the expiration
of the 18-day period beginning on the issuance of the earnings release, unless the Placement Agent waives such extension.

 

No
provision in this agreement shall be deemed to restrict or prohibit the exercise or exchange by the undersigned of any option
or warrant to acquire Shares, or securities exchangeable or exercisable for or convertible into Shares, provided that the
undersigned does not transfer the acquired on such exercise or exchange during the Lock-Up Period, unless otherwise permitted
pursuant to the terms of this letter agreement. In addition, no provision herein shall be deemed to restrict or prohibit the entry
into or modification of a so-called “10b5-1” plan at any time (other than the entry into or modification of such a
plan in such a manner as to cause the sale of any Shares or any securities convertible into or exercisable or exchangeable for
Shares within the Lock-Up Period).

 

    	 

    	 

    

 

The
undersigned understands that the Company and the Placement Agent are relying upon this letter agreement in proceeding toward consummation
of the Public Offering. The undersigned further understands that this agreement is irrevocable and shall be binding upon the undersigned’s
heirs, legal Placement Agents, successors and assigns.

 

The
undersigned understands that, if the Placement Agency Agreement is not executed by the Company, or if the Placement Agency Agreement
(other than the provisions thereof which survive termination) shall terminate or be terminated prior to payment for and delivery
of Shares to be sold thereunder this agreement shall be void and of no further force or effect.

 

Whether
or not the Public Offering actually occurs depends on a number of factors, including market conditions. Any Public Offering will
only be made pursuant to an Placement Agency Agreement, the terms of which are subject to negotiation between the Company and
the Placement Agent.

 

	 	Very
    truly yours,
	 	 
	 	 
	 	(Name):
	 	 
	 	 
	 	(Address)

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00284-of-00352.parquet"}]]